var title_f22_56_23424="Perivascular staining retina";
var content_f22_56_23424=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F66049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F66049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Perivascular staining on fluorescein angiography in retinal vasculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fluorescein angiogram in a patient with retinal vasculitis and systemic lupus erythematosus shows perivascular staining.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of M Reza Dana, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23424=[""].join("\n");
var outline_f22_56_23424=null;
var title_f22_56_23425="Calculator: MDACC Myelodysplastic syndrome prognostic model";
var content_f22_56_23425=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"MDACC_form\" name=\"MDACC_form\" onreset=\"rrclr();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: MDACC Myelodysplastic syndrome prognostic model",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_main\">",
"     <div id=\"calc_input\">",
"      <center>",
"       <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontCCTabBold\">",
"           Age",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc1\" onclick=\"MDACC_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Less than 60 years old (0 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc1\" onclick=\"MDACC_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           60 to 64 years old (1 point)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc1\" onclick=\"MDACC_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           &gt;=65 years old (2 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontCCTabBold\">",
"           Clinical indicators",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc2\" onclick=\"MDACC_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Performance status of 2 or higher (2 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc3\" onclick=\"MDACC_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           History of prior transfusion (1 point)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontCCTabBold\">",
"           Blood counts",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc4\" onclick=\"MDACC_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Platelet count &gt;=200 x 10",
"           <sup>",
"            9",
"           </sup>",
"           /L (0 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc4\" onclick=\"MDACC_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Platelet count 50-199 x 10",
"           <sup>",
"            9",
"           </sup>",
"           /L (1 point)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc4\" onclick=\"MDACC_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Platelet count 30-49 x 10",
"           <sup>",
"            9",
"           </sup>",
"           /L (2 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc4\" onclick=\"MDACC_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Platelet count &lt;30 x 10",
"           <sup>",
"            9",
"           </sup>",
"           /L (3 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc5\" onclick=\"MDACC_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Hemoglobin &lt;12 g/dL (2 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc6\" onclick=\"MDACC_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           White blood count &gt;20 x 10",
"           <sup>",
"            9",
"           </sup>",
"           /L (2 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontCCTabBold\">",
"           Bone marrow",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc7\" onclick=\"MDACC_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Blasts &lt;5 percent (0 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc7\" onclick=\"MDACC_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Blasts 5 to 10 percent (1 point)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc7\" onclick=\"MDACC_fx();\" type=\"radio\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Blasts &gt;10 percent (2 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontCCTabBold\">",
"           Karyotype",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc8\" onclick=\"MDACC_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Chromosome 7 abnormality or complex &gt;=3 abnormalities (3 points)",
"          </span>",
"         </td>",
"        </tr>",
"       </table>",
"      </center>",
"     </div>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <div id=\"calc_result\">",
"      <span class=\"medCalcFontCCTabBold\">",
"       Total Criteria Point Count:",
"      </span>",
"      <input name=\"cctotal\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      <center>",
"       <input name=\"reset\" type=\"reset\" value=\"Reset Form\"/>",
"      </center>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"70%\">",
"       <tr>",
"        <td bgcolor=\"#eeeeee\" width=\"1%\">",
"         <br/>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <span class=\"medCalcFontTitleBox\">",
"          Estimates of Survival based on MDACC Score",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      <center>",
"       <table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" summary=\"RRTable\">",
"        <tr id=\"rr1_1\">",
"         <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px;\">",
"          <span class=\"medCalcFontOneBold\">",
"           0 to 4 points:",
"          </span>",
"         </td>",
"         <td align=\"left\" style=\"border-left: 0px;\">",
"          <span class=\"medCalcFontOne\">",
"           54 months median: 63 percent at three years; &nbsp;38 percent at six years",
"          </span>",
"         </td>",
"        </tr>",
"        <tr id=\"rr1_2\">",
"         <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px;\">",
"          <span class=\"medCalcFontOneBold\">",
"           5 to 6 points:",
"          </span>",
"         </td>",
"         <td align=\"left\" style=\"border-left: 0px;\">",
"          <span class=\"medCalcFontOne\">",
"           25 months median: 34 percent at three years; &nbsp;13 percent at six years",
"          </span>",
"         </td>",
"        </tr>",
"        <tr id=\"rr1_3\">",
"         <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px;\">",
"          <span class=\"medCalcFontOneBold\">",
"           7 to 8 points:",
"          </span>",
"         </td>",
"         <td align=\"left\" style=\"border-left: 0px;\">",
"          <span class=\"medCalcFontOne\">",
"           14 months median: 16 percent at three years; &nbsp;&nbsp;6 percent at six years",
"          </span>",
"         </td>",
"        </tr>",
"        <tr id=\"rr1_4\">",
"         <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px;\">",
"          <span class=\"medCalcFontOneBold\">",
"           9 to 17 points:",
"          </span>",
"         </td>",
"         <td align=\"left\" style=\"border-left: 0px;\">",
"          <span class=\"medCalcFontOne\">",
"           &nbsp;6 months median: &nbsp;4 percent at three years; 0.4 percent at six years",
"          </span>",
"         </td>",
"        </tr>",
"       </table>",
"      </center>",
"     </div>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"     </span>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Kantarjian H, O'Brien S, Ravandi F, et. al. Proposal for a new risk model in myelodysplastic syndrome that accounts for events  not considered in the original International Prognostic Scoring System.",
"        <i>",
"         Cancer",
"        </i>",
"        . 2008 Sep 15; 113:1351-61.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"   <script language=\"JavaScript1.1\" type=\"text/javascript\">",
"    &lt;!--",
"",
";",
"MDACC_fx();",
"//--&gt;",
"   </script>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23425=[" ",
"",
"var calctxt = '';",
"var xmltxt = '';",
"var htmtxt = '';",
"",
"",
"function MDACC_fx() {",
"with(document.MDACC_form){",
"",
"Score = 0.0;",
"doCalc = true;",
"",
"if (cc1[0].checked){",
"Score = Score + 0;",
"}",
"if (cc1[1].checked){",
"Score = Score + 1;",
"}",
"if (cc1[2].checked){",
"Score = Score + 2;",
"}",
"if (cc2.checked){",
"Score = Score + 2;",
"}",
"if (cc3.checked){",
"Score = Score + 1;",
"}",
"if (cc4[0].checked){",
"Score = Score + 0;",
"}",
"if (cc4[1].checked){",
"Score = Score + 1;",
"}",
"if (cc4[2].checked){",
"Score = Score + 2;",
"}",
"if (cc4[3].checked){",
"Score = Score + 3;",
"}",
"if (cc5.checked){",
"Score = Score + 2;",
"}",
"if (cc6.checked){",
"Score = Score + 2;",
"}",
"if (cc7[0].checked){",
"Score = Score + 0;",
"}",
"if (cc7[1].checked){",
"Score = Score + 1;",
"}",
"if (cc7[2].checked){",
"Score = Score + 2;",
"}",
"if (cc8.checked){",
"Score = Score + 3;",
"}",
"cctotal.value = Score;",
"",
"if (doCalc){",
"rrclr();",
"if ((Score >= 0) && (Score <= 4)){ document.getElementById('rr1_1').bgColor = '#cccccc';",
"}",
"if ((Score >= 5) && (Score <= 6)){ document.getElementById('rr1_2').bgColor = '#cccccc';",
"}",
"if ((Score >= 7) && (Score <= 8)){ document.getElementById('rr1_3').bgColor = '#cccccc';",
"}",
"if ((Score >= 9) && (Score <= 17)){ document.getElementById('rr1_4').bgColor = '#cccccc';",
"}",
"",
"}",
"}",
"}",
"",
"",
"",
"",
"function rrclr(){",
"document.getElementById('rr1_1').bgColor = \"\";",
"document.getElementById('rr1_2').bgColor = \"\";",
"document.getElementById('rr1_3').bgColor = \"\";",
"document.getElementById('rr1_4').bgColor = \"\";",
"}",
"",
"",
""].join("\n");
var outline_f22_56_23425=null;
var title_f22_56_23426="Disseminated intravascular coagulation";
var content_f22_56_23426=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61719&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61719&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Retiform purpura in disseminated intravascular coagulation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Widespread retiform purpura are present in this patient with disseminated intravascular coagulation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23426=[""].join("\n");
var outline_f22_56_23426=null;
var title_f22_56_23427="Patient information: Wolff-Parkinson-White syndrome (The Basics)";
var content_f22_56_23427=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?20/32/20994\">",
"         Patient information: Atrial fibrillation (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/60/38850\">",
"         Patient information: Implantable cardioverter-defibrillators (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/49/6931\">",
"         Patient information: Pacemakers (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?12/54/13154\">",
"         Patient information: Radiofrequency catheter ablation for the heart (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?0/16/261\">",
"         Patient information: Atrial fibrillation (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/10/24738\">",
"         Patient information: Cardioversion (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/20/11589\">",
"         Patient information: Implantable cardioverter-defibrillators (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?14/31/14834\">",
"         Patient information: Radiofrequency catheter ablation for the heart (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?8/50/8995\">",
"         Patient information: Wolff-Parkinson-White syndrome (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Wolff-Parkinson-White syndrome (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/wolff-parkinson-white-syndrome-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H560846823\">",
"      <span class=\"h1\">",
"       What is Wolff-Parkinson-White syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Wolff-Parkinson-White (WPW) syndrome is a condition that can cause episodes of dizziness or fainting.",
"     </p>",
"     <p>",
"      People with WPW syndrome can have episodes when their heart beats much faster than normal. This can cause symptoms. The fast heartbeat can come and go suddenly. Sometimes, a fast heartbeat goes back to normal on its own. Other times, treatment is needed.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H560846830\">",
"      <span class=\"h1\">",
"       How do normal heartbeats happen?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A normal heartbeat happens when an electrical signal starts in one spot near the top of the heart. This electrical signal follows a path to spread across the heart. As it spreads, the signal causes the heart muscle to squeeze. Each time the heart squeezes, blood is sent all over the body. Normally, the heart beats in a regular way 60 to 80 times a minute.",
"     </p>",
"     <p>",
"      People can have abnormal heartbeats if:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        The electrical signal does not start in the right place",
"       </li>",
"       <li>",
"        The electrical signal does not follow the right path as it spreads across the heart",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H560846837\">",
"      <span class=\"h1\">",
"       Why is the heartbeat abnormal in WPW syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The heartbeat can be abnormal in WPW syndrome, because people with WPW syndrome have an abnormal extra path in the heart. When the electrical signal follows the abnormal extra path, the heart can beat at a rate that is much faster than normal.",
"     </p>",
"     <p>",
"      Some people have an abnormal extra path in their heart, but they do not have a fast heartbeat. These people do not have any symptoms and do not have WPW syndrome. Instead, they have a &ldquo;WPW pattern.&rdquo; These people usually do not need treatment.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H560846844\">",
"      <span class=\"h1\">",
"       What are the symptoms of WPW syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with WPW syndrome can have symptoms that include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Feeling their heart beating too fast",
"       </li>",
"       <li>",
"        Feeling dizzy or light-headed",
"       </li>",
"       <li>",
"        Fainting",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Most people with WPW syndrome do not have any other heart problems, but some do. People with WPW syndrome who have other heart problems can have more serious symptoms. These include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Chest pain",
"       </li>",
"       <li>",
"        Trouble breathing",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      WPW syndrome can be life-threatening, because it can cause sudden death. But this is rare.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H560846851\">",
"      <span class=\"h1\">",
"       Is there a test for WPW syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Doctors can diagnose WPW syndrome by doing a test called an &ldquo;electrocardiogram&rdquo; (ECG). An ECG measures the electrical activity in the heart. It can show if a person has an abnormal heart rhythm or rate.",
"     </p>",
"     <p>",
"      Sometimes, a doctor will do another procedure to figure out where the extra path is and if it needs to be treated.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H560846858\">",
"      <span class=\"h1\">",
"       How is WPW syndrome treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;WPW syndrome is treated in different ways. Some treatments can stop episodes of fast heartbeats. Other treatments can prevent episodes of fast heartbeats from happening in the future.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H560846865\">",
"      <span class=\"h1\">",
"       What treatments can stop a fast heartbeat?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments that can control a fast heartbeat include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Actions &ndash; Actions that people can do themselves include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Coughing or &ldquo;bearing down&rdquo; &ndash; Bearing down is when a person tightens his or her belly as if he or she is trying to have a bowel movement.",
"       </li>",
"       <li>",
"        Pressing on and massaging the main artery on the side of the neck",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Medicines",
"       </li>",
"       <li>",
"        A procedure called &ldquo;cardioversion&rdquo; &ndash; During cardioversion, a doctor gives a person&rsquo;s heart an electric shock to stop the fast heartbeat. This allows the heart to beat normally again.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H560846872\">",
"      <span class=\"h1\">",
"       What treatments can prevent future episodes of fast heartbeats?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments that can prevent future episodes of fast heartbeats include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A procedure called &ldquo;radiofrequency catheter ablation&rdquo; &ndash; This procedure can stop the abnormal path from spreading the electrical signal. During the procedure, a doctor puts thin wires into the blood vessels in the groin (inner thigh) or another part of the body. He or she threads the wires up through the blood vessels and into the heart. Then he or she uses the wires to disconnect the abnormal path.",
"       </li>",
"       <li>",
"        Medicines &ndash; Some people need to take medicines every day.",
"       </li>",
"       <li>",
"        Surgery &ndash; A doctor can do surgery to disconnect the abnormal path in the heart. But radiofrequency catheter ablation is done more often than surgery.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H560846879\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/54/13154?source=see_link\">",
"       Patient information: Radiofrequency catheter ablation for the heart (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/60/38850?source=see_link\">",
"       Patient information: Implantable cardioverter-defibrillators (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/32/20994?source=see_link\">",
"       Patient information: Atrial fibrillation (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/49/6931?source=see_link\">",
"       Patient information: Pacemakers (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?8/50/8995?source=see_link\">",
"       Patient information: Wolff-Parkinson-White syndrome (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/31/14834?source=see_link\">",
"       Patient information: Radiofrequency catheter ablation for the heart (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/10/24738?source=see_link\">",
"       Patient information: Cardioversion (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?11/20/11589?source=see_link\">",
"       Patient information: Implantable cardioverter-defibrillators (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/16/261?source=see_link\">",
"       Patient information: Atrial fibrillation (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?22/56/23427?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15669 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-11D65C23BF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23427=[""].join("\n");
var outline_f22_56_23427=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H560846823\">",
"      What is Wolff-Parkinson-White syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H560846830\">",
"      How do normal heartbeats happen?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H560846837\">",
"      Why is the heartbeat abnormal in WPW syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H560846844\">",
"      What are the symptoms of WPW syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H560846851\">",
"      Is there a test for WPW syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H560846858\">",
"      How is WPW syndrome treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H560846865\">",
"      What treatments can stop a fast heartbeat?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H560846872\">",
"      What treatments can prevent future episodes of fast heartbeats?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H560846879\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/16/261?source=related_link\">",
"      Patient information: Atrial fibrillation (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/32/20994?source=related_link\">",
"      Patient information: Atrial fibrillation (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/10/24738?source=related_link\">",
"      Patient information: Cardioversion (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/20/11589?source=related_link\">",
"      Patient information: Implantable cardioverter-defibrillators (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/60/38850?source=related_link\">",
"      Patient information: Implantable cardioverter-defibrillators (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/49/6931?source=related_link\">",
"      Patient information: Pacemakers (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/31/14834?source=related_link\">",
"      Patient information: Radiofrequency catheter ablation for the heart (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/54/13154?source=related_link\">",
"      Patient information: Radiofrequency catheter ablation for the heart (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/50/8995?source=related_link\">",
"      Patient information: Wolff-Parkinson-White syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_56_23428="Ulnar nerve distribution";
var content_f22_56_23428=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F75124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F75124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 478px\">",
"   <div class=\"ttl\">",
"    Ulnar nerve distribution",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 458px; height: 608px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagram of the ulnar nerve and the muscles which it supplies.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Aids to the examination of the peripheral nervous system. The Guarantors of Brain. London: Bailliere Tindall, 1986. Illustration used with the permission of Elseiver Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23428=[""].join("\n");
var outline_f22_56_23428=null;
var title_f22_56_23429="Nabumetone: Patient drug information";
var content_f22_56_23429=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Nabumetone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/18/39208?source=see_link\">",
"     see \"Nabumetone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F198809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Nabumetone&reg;;",
"     </li>",
"     <li>",
"      Gen-Nabumetone;",
"     </li>",
"     <li>",
"      Mylan-Nabumetone;",
"     </li>",
"     <li>",
"      Novo-Nabumetone;",
"     </li>",
"     <li>",
"      Relafen&reg;;",
"     </li>",
"     <li>",
"      Rhoxal-nabumetone;",
"     </li>",
"     <li>",
"      Sandoz-Nabumetone",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10030063\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700782",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of very bad and sometimes deadly heart and blood vessel side effects like heart attack and stroke. The risk may be greater if you have heart disease or risks for heart disease. The risk may be greater with long-term use. Do not use this drug right before or after bypass heart surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700792",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of ulcers or bleeding from the stomach or bowel. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10030065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691600",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain and swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691733",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat arthritis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10030064\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702559",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to nabumetone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 24 weeks pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10030069\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697235",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had an ulcer or bleeding from your stomach or bowel, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696862",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take colestipol or cholestyramine within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10030070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain or heartburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10030072\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling or pain of hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black, tarry, or bloody stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood in the urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10030067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food to stop an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10030068\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10030073\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10030074\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10883 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-A1721555EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23429=[""].join("\n");
var outline_f22_56_23429=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F198809\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030063\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030065\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030064\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030069\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030070\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030072\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030067\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030068\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030073\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030074\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?38/18/39208?source=related_link\">",
"      Nabumetone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_56_23430="Formoterol: Patient drug information";
var content_f22_56_23430=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Formoterol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/52/14151?source=see_link\">",
"     see \"Formoterol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/26/11686?source=see_link\">",
"     see \"Formoterol: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F174082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Foradil&reg; Aerolizer&reg;;",
"     </li>",
"     <li>",
"      Perforomist&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F174083\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Foradil&reg;;",
"     </li>",
"     <li>",
"      Oxeze&reg; Turbuhaler&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10016234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700378",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In patients with asthma, long-acting puffers (inhalers) raised asthma-related deaths. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691735",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat asthma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691790",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat COPD (chronic obstructive pulmonary disease).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691447",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is used to stop exercise-induced breathing problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to formoterol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701034",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to milk, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3378219",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are",
"       <b>",
"        not",
"       </b>",
"       using other asthma drugs. This drug must be used with a long-term asthma-control drug like a breathed in steroid.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701052",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are having a breathing attack.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697133",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a fast heartbeat, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697325",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have pheochromocytoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697166",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an overactive thyroid, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3532549",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain or heartburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699102",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to get the breathing attack under control.",
"       <b>",
"        Get help right away.",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698996",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Peak flow measurement low.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698964",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor right away if your normal dose does not work as well or if you need to use your inhaler more often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016238\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For breathing in only by a puffer (inhaler) or as a liquid (solution) by a special machine (nebulizer) into the lungs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        Do not swallow capsule or liquid. The contents of this drug will be breathed into the lungs.",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705423",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Puffer (inhaler):",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694582",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your puffer (inhaler) use checked with your doctor at each visit. Read and follow facts on how to use the puffer. Make sure you use the puffer the right way.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rinse out mouth after each use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use a spacer with the puffer (inhaler).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696176",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use new puffer (inhaler) with each refill.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694799",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use this drug more than 2 times in a day. Space doses by about 12 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If working out or playing sports causes signs, use at least 15 minutes before doing it. Do not take more doses for at least 12 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705466",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Nebulizer:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694799",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use this drug more than 2 times in a day. Space doses by about 12 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694731",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not mix other drugs in nebulizer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696538",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis for asthma caused by working out. Do not take more often than every 12 hours unless told to do so by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705398",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Foradil&reg; Aerolizer&trade;:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699370",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store capsules in the original container. Use right after opening.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699262",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from heat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705502",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Perforomist&reg;:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3872622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature for up to 3 months.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699403",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in foil pouch until ready for use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699642",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use right after opening.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any unused part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699262",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from heat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11737 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-202.43.93.2-481E12C6DB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23430=[""].join("\n");
var outline_f22_56_23430=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174082\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174083\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016234\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016236\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016235\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016240\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016241\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016243\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016238\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016239\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016244\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016245\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/52/14151?source=related_link\">",
"      Formoterol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/26/11686?source=related_link\">",
"      Formoterol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_56_23431="Preimplantation genetic diagnosis";
var content_f22_56_23431=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Preimplantation genetic diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/56/23431/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/56/23431/contributors\">",
"     Glenn L Schattman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/56/23431/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/56/23431/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/56/23431/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/56/23431/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/56/23431/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two types of preimplantation genetic testing:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Preimplantation genetic diagnosis (PGD)",
"      </strong>",
"      is performed on cell(s) removed from a preimplantation embryo or a polar body from an oocyte. The goal is to establish a pregnancy that is unaffected by specific genetic characteristics, such as a known heritable genetic mutation or chromosomal abnormality (eg, translocations) carried by one or both biological parents. It is also used to select embryos for transfer that have specific characteristics, such as a particular gender or compatible HLA type.",
"     </li>",
"     <li>",
"      <strong>",
"       Preimplantation genetic screening (PGS)",
"      </strong>",
"      is performed on cell(s) removed from a preimplantation embryo or a polar body from an oocyte. The goal is to identify de-novo aneuploidy in embryo(s) of couples presumed to be chromosomally normal. Theoretically, avoiding transfer of aneuploid embryos will reduce the risk of pregnancy failure and improve the probability of conceiving a viable pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When preimplantation genetic testing is planned, assisted reproductive technology (ART) must be used for conception even if infertility is not an issue for the couple. ART is expensive, intrusive, and associated with risks, such as ovarian hyperstimulation syndrome, multiple gestations and risks to singleton gestations, that occur less frequently in natural conceptions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37770?source=see_link\">",
"     \"In vitro fertilization\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15546?source=see_link\">",
"     \"Intracytoplasmic sperm injection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OBTAINING DNA FOR ANALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic testing is performed on DNA from a cell removed from an oocyte or preimplantation embryo. The DNA must be obtained at a time when removal does not disrupt the ability of the oocyte or embryo to progress in its normal development. Micromanipulations required for PGD do not appear to adversely affect embryo development to the blastocyst stage, but the process can result in the loss of some embryos that are biopsied [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To obtain genetic material for analysis, a laser, acid Tyrode's solution, or a sharpened glass needle is used to create an opening in the zona pellucida [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. The polar body, blastomere (ie, a cell produced during cleavage of a fertilized egg), or trophectoderm cells (ie, cells from the outer layer of the blastocyst destined to form the placenta) are extracted using a small pipette and gentle suction or by gently compressing the oocyte or early embryo to extrude the cells through the defect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Polar body biopsy (PBB)",
"    </span>",
"    &nbsp;&mdash;&nbsp;PBB is only useful for evaluation of maternally-inherited mutations. The genetic composition of the oocyte can be inferred from analysis of the first and, sometimes, the second polar body [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. If the mother is heterozygous for a known mutant allele, division of the diploid primary oocyte at meiosis I may result in a normal (\"wild-type\") secondary oocyte and a first polar body with the same mutant allele (",
"    <a class=\"graphic graphic_figure graphicRef53222 \" href=\"UTD.htm?26/61/27606\">",
"     figure 1",
"    </a>",
"    ). PBBs that demonstrate normal alleles are presumed to be associated with oocytes that have the mutant alleles: these oocytes would not be used to achieve pregnancy. Conversely, PBBs demonstrating the mutant alleles are presumed to be associated with oocytes with normal alleles and these oocytes are then used for in vitro fertilization.",
"   </p>",
"   <p>",
"    One disadvantage of PBB is the genetic phenomenon of recombination (\"crossing-over\") that occurs during meiosis between homologous chromosomes. If a single crossing-over event involves the region containing the candidate gene, the single chromosome would not contain both alleles. Specifically, the two chromatids of the single chromosome would become heterozygous and thus biopsy of only the first polar body would not permit an accurate prediction of the genetic composition of the oocyte. This problem can be addressed by removal and analysis of both polar bodies (",
"    <a class=\"graphic graphic_figure graphicRef53222 \" href=\"UTD.htm?26/61/27606\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/9\">",
"     9",
"    </a>",
"    ]. The likelihood of recombination and diagnostic errors is increased for genes close to the telomeric (distal) region of the chromosome, as genes closer to the centromeric (central) region are far less likely to cross over.",
"   </p>",
"   <p>",
"    PBB is not useful if the mother is affected (homozygous) by an autosomal recessive disorder since all of her oocytes will carry the mutation. Blastomere or blastocyst biopsy to assess both maternal and paternal genes in the developing embryos is necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Blastomere biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The embryo typically contains six to nine cells on day 3 after fertilization. Compaction of the embryo has not yet occurred so one or two nucleated cells (blastomeres) can be teased apart from their sibling blastomeres and removed for genetic analysis relatively easily. A randomized trial showed that embryonic development was reduced if more than one blastomere was removed at this stage, but more than one cell may be needed because biopsy of only one cell significantly lowered the efficiency of a PCR-based diagnosis (the efficiency of the fluorescence in situ hybridization [FISH] PGD procedure remained similar whether one or two cells were removed) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/10\">",
"     10",
"    </a>",
"    ]. Delivery rates (live birth per started cycle), however, were not affected by the removal of the second cell. Genetic analysis must be completed by day 6 after fertilization, or the embryo must be frozen, because implantation should occur by that time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Blastocyst biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;By five to six days following fertilization, the blastocyst contains hundreds of cells. Biopsy of trophectoderm cells overlying the anembryonic pole can provide two to three dozen cells for genetic analysis. Compared to other techniques for obtaining preimplantation DNA, blastocyst biopsy is the least disruptive to subsequent development while providing the most DNA for testing, which reduces the possibility of diagnostic errors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/11\">",
"     11",
"    </a>",
"    ]. Unfortunately, there is a significant loss of embryos in vitro between the eight cell and blastocyst stage because of laboratory-related factors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/12\">",
"     12",
"    </a>",
"    ]. Additionally, blastocysts developed in vitro appear to be at increased risk of monozygotic twinning [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/13\">",
"     13",
"    </a>",
"    ]. Biopsy of embryos that have developed to the blastocyst stage, however, might reduce overall cost since fewer embryos, only those that are the most viable, are biopsied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     GENETIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many genetic disorders are caused by single-gene defects. These genetic defects often involve a mutation in a single base pair that results in abnormal protein secretion. To detect differences in gene sequences between cells, polymerase chain reaction (PCR) is used to amplify the segment of the genome that contains the specific gene of interest. Nested primer PCR provides the means to obtain millions of copies of the gene of interest and test for mutations using mutation-specific primers, digestion with restriction enzymes, or heteroduplex analysis. Amplification of the entire genome and analysis with CGH or microarrays, as well as genome sequencing, is currently being evaluated as another method for detecting single gene defects along with aneuploidy, however, data on clinical outcomes are lacking. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/54/13159?source=see_link\">",
"     \"Polymerase chain reaction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=see_link\">",
"     \"Cytogenetic and molecular genetic diagnostic tools\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Numerical chromosomal abnormalities in oocytes or embryos from patients with balanced translocations can be evaluated using fluorescence in situ hybridization (FISH), which can be performed directly on the interphase nucleus of the biopsied cell. DNA probes labeled with distinctly colored fluorochromes that bind to specific DNA sequences unique to the chromosome segment of interest are used to detect missing or excess chromosomal material in polar bodies (when the female partner is the carrier) or embryos (when either partner is the carrier) of individuals known to harbor the translocation or other structural rearrangement [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. Initially, the requirement to develop unique telomeric probes for each patient limited the development of this technology, however, an abundance of probes are now commercially available without the need to develop unique probes for each patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=see_link\">",
"     \"Cytogenetic and molecular genetic diagnostic tools\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Due to the limitations, as well as the error rate of FISH technology, this technique is rarely used to detect aneuploidies. More recently, numerical chromosomal abnormalities (aneuploidies) have been successfully identified from polar bodies or blastomeres using array CGH, single nucleotide polymorphism (SNP) arrays, or DNA sequencing. These methods also enable detection of small chromosomal deletions and duplications not detectable by FISH or conventional G-banded karyotype analysis. In addition, multiple mutations can be screened simultaneously. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=see_link\">",
"     \"Cytogenetic and molecular genetic diagnostic tools\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/2/7208?source=see_link\">",
"     \"Use of array comparative genomic hybridization (aCGH) in obstetrics\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the cell removed for analysis has no nucleus, no DNA amplification will occur and no diagnosis can be made. If failure of amplification occurs, the embryo can be rebiopsied at the blastocyst stage and transferred based on the results of this testing. Alternatively, errors can result when one allele for the gene of interest fails to amplify (\"allele drop-out\") or amplifies poorly (\"partial amplification\"). Both types of technical failure have been described and have resulted in misdiagnoses after single-cell PCR, leading to the transfer of an affected embryo believed to be normal, or the discarding of a normal embryo thought to be affected (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Counseling'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Inadvertent amplification of contaminating extraneous DNA can lead to false negative results and transfer of abnormal embryos thought to be normal. Laboratories performing PCR on single cells must take extra precautions to prevent this error.",
"   </p>",
"   <p>",
"    False negative errors for many diseases have occurred following IVF with PGD. The true risk for obtaining a clinically relevant false negative result can be determined only by further genetic testing of all conceptions after PGD, but no such studies have been conducted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     REASONS COUPLES CHOOSE TO UNDERGO PGD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conventional prenatal diagnostic techniques (amniocentesis, chorionic villus sampling, fetal blood sampling) are performed weeks to months after implantation of the pregnancy. If test results show that the fetus carries an undesired genetic characteristic, the only available intervention is pregnancy termination.",
"   </p>",
"   <p>",
"    By comparison, PGD enables establishment of pregnancies that are unaffected by specific known genetic characteristics. However, in vitro fertilization with or without intracytoplasmic sperm injection is required even though many of these couples have no known difficulties conceiving a pregnancy. The inconvenience, risks, and expense of these additional procedures limit the actual utilization of this technology by couples at risk of transmitting a genetic disease or attempting to select for specific characteristics in offspring. Nevertheless, surveys of couples at high risk of transmitting a genetic disorder report that 30 to 74 percent would prefer PGD to conventional prenatal diagnosis procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following clinical situations illustrate potential reasons couples choose to conceive via ART and undergo PGD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Unable or unwilling to undergo pregnancy termination of an affected fetus",
"    </span>",
"    &nbsp;&mdash;&nbsp;PGD gives couples the ability to reduce the likelihood of an in utero pregnancy in which the fetus is ascertained to have inherited a familial disorder. This is important for couples who would be unable or unwilling to terminate an affected pregnancy, but are able to discard affected oocytes and preimplantation embryos.",
"   </p>",
"   <p>",
"    Some genetic mutations do not cause disease, but confer an increased risk of developing a disease. As an example, BRCA mutation carriers have a predisposition to developing breast and ovarian cancer. Some couples choose to use PGD to avoid the transfer of embryos with these types of mutations, given the increased risk of serious disease and the stress associated with this knowledge.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Reduce high risk of recurrent pregnancy loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 2 to 4 percent of couples experiencing recurrent pregnancy loss will have one partner with an identifiable balanced translocation as a potential cause of the losses. There is an increased risk that the partner's gametes will have an unbalanced genetic composition due to excess or missing genetic material. Embryos derived from these unbalanced gametes will usually miscarry. PGD of the oocytes or embryos using telomeric probes for the translocated segment and avoiding",
"    <span class=\"nowrap\">",
"     fertilization/transfer",
"    </span>",
"    of these",
"    <span class=\"nowrap\">",
"     gametes/embryos",
"    </span>",
"    appears to significantly reduce the frequency of miscarriage [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/18-20\">",
"     18-20",
"    </a>",
"    ], although it might not enhance the overall probability of live birth [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/21\">",
"     21",
"    </a>",
"    ]. In one literature review including six studies, the rate of miscarriage without PGD ranged from 26 to 64 percent versus 5 to 15 percent with PGD [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/20\">",
"     20",
"    </a>",
"    ]. This review also observed that use of PGD appeared to shorten the time it took to conceive a pregnancy that resulted in live birth [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Increase chances of giving birth to a child with a compatible HLA type for stem cell therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stem cell transplantation has significantly improved the prognosis for many life-threatening diseases. One such example is children affected with Fanconi's anemia. Identification of a disease-free embryo that is also HLA compatible to the affected child and can provide cord blood stem cells for transplantation will significantly improve the probability of survival of the affected sibling. PGD has been used successfully to identify HLA-compatible unaffected embryos to permit treatment of an affected sibling by cord blood transfusion or bone marrow transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/47/11002?source=see_link\">",
"     \"Collection and storage of umbilical cord blood for hematopoietic cell transplantation\"",
"    </a>",
"    .) One caveat of this remarkable technology is that very few of the embryos tested (about 16 percent) will be both unaffected and an HLA match for the affected sibling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Preimplantation sex selection to avoid sex-linked disorders in offspring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ideally, PGD would identify unaffected males so that these embryos, as well as noncarrier females, could be transferred preferentially. In situations where the gene mutation causing the disease is on a sex chromosome but has not yet been identified or the disease preferentially affects children of one sex (ie, autism has a 4:1 male-to-female ratio), PGD for the presence or absence of the Y chromosome enables the clinician to limit transfer of embryos to only those of the desired gender [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/23\">",
"     23",
"    </a>",
"    ]. In a large European database, Duchenne muscular dystrophy and hemophilia were the most common medical conditions where preimplantation sex selection was utilized [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sex selection for social reasons is more controversial. The American College of Obstetricians and Gynecologists and American Society for Reproductive Medicine ethics committees are unanimous in their position against offering sex selection in the absence of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Sex selection in the absence of a medical indication, however, is being performed and was the reason for PGD in 2.3 percent of PGD cases in the European database, based on voluntary reporting [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/36/29256?source=see_link\">",
"     \"Techniques for preimplantation sex selection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Avoid passing a suspected but unconfirmed autosomal dominant disease to offspring",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the most difficult situations encountered in centers performing PGD is the request for testing embryos for late onset autosomal dominant diseases (eg, Huntington's chorea). Patients often present when an older parent is diagnosed and they are made aware that they have a 50 percent chance of carrying the mutation causing disease. Many patients do not want to know if they are carriers of the mutated gene for personal and insurance reasons; however, if they inherited it from their parent, they want to make sure that they do not pass the gene to their offspring.",
"   </p>",
"   <p>",
"    In these situations, PGD with \"non-disclosure\" can be performed. The patient undergoes an egg retrieval, the eggs are fertilized, but the results (number of eggs, embryos, the number of embryos transferred, the results of the genetic testing) are not divulged to the patient. If the genetic parent is a carrier, disclosing this information might tip them off to their genetic status. If there are no normal embryos available, sometimes a \"mock\" embryo transfer with no actual embryos being transferred is performed.",
"   </p>",
"   <p>",
"    A challenging ethical situation is when the patient is found not to be a carrier of the mutation, based on the results of the initial cycle of in vitro fertilization (IVF) and PGD. Since providing this information would constitute disclosure, some clinicians would not inform the patient and allow the patient to plan and undertake future pregnancies using IVF and PGD, despite costs and risks involved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     COUNSELING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Couples who are considering PGD must be aware of its limitations, as well as the risk of misdiagnosis. Therefore, counseling by an experienced individual prior to proceeding is extremely important [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/1\">",
"     1",
"    </a>",
"    ]. The following points are key elements of the counseling process and informed consent.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Causes of unanticipated birth of an affected offspring include: unprotected sex resulting in pregnancy, transfer of the wrong embryo and other human errors, haploid cells, contamination, allele drop out, and uniparental disomy [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The actual rate of misdiagnosis, if known, should be discussed. It can be difficult to define since misdiagnosed embryos that don't result in live births are not recognized. The risk for misdiagnosis due to allele drop-out or partial amplification depends directly on the type of genetic disorder for which testing is performed [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/28-30\">",
"       28-30",
"      </a>",
"      ]. The estimated risk of transferring an affected embryo mistakenly identified as normal by PGD is approximately 2 percent for recessive disorders and 11 percent for dominant disorders [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/31\">",
"       31",
"      </a>",
"      ]. Analysis for linked markers will reduce this error rate significantly.",
"      <br/>",
"      <br/>",
"      The European Society of Human Reproduction and Embryology Preimplantation Genetic Diagnosis Consortium offers members the ability to report misdiagnoses anonymously. As of 2005, 24 misdiagnoses and adverse outcomes were reported in 15,158 cycles (0.16 percent);",
"      <span class=\"nowrap\">",
"       12/2538",
"      </span>",
"      cycles (0.5 percent) after polymerase chain reaction and",
"      <span class=\"nowrap\">",
"       12/12,620",
"      </span>",
"      cycles (0.1 percent) after fluorescence in situ hybridization [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/27\">",
"       27",
"      </a>",
"      ]. These low rates possibly reflect the fact that reporting of misdiagnoses was optional or the low implantation rate of aneuploidy embryos.",
"     </li>",
"     <li>",
"      Confirmatory conventional prenatal testing with chorionic villus sampling (CVS) or amniocentesis is recommended for all pregnancies conceived after PGD to avoid misdiagnosis.",
"     </li>",
"     <li>",
"      False positive results may lead to the discard of potentially normal embryos and thus lower the chances for pregnancy.",
"     </li>",
"     <li>",
"      The embryo biopsy procedure itself may negatively affect the viability of the embryo and lower the probability of pregnancy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Alternative approaches should be discussed, such as use of donor gametes presumed to be free of the mutation, conventional prenatal testing, and even no testing, adoption, and childlessness. Lastly, the fate of embryos not transferred either due to lack of viability or an abnormal result should be decided upon prior to undergoing IVF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SAFETY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of clinical outcomes of pregnancies evaluated by PGD is limited by the relatively small number of living offspring and short length of follow-up after birth. Continuing surveillance of this technology is obviously needed; the International Preimplantation Genetic Diagnosis Consortium, the Society for Assisted Reproductive Technology (SART), and the PGD Consortium of ESHRE are providing the needed resources for monitoring clinical outcomes of PGD pregnancies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Implantation rate &mdash; It is possible that embryo biopsy negatively affects the ability of the embryo to implant and develop. This effect may be related to the population that undergoes PGD, maternal age, and the number and quality of embryos, but more data are needed [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/32,33\">",
"       32,33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The ESHRE database through 2007 reported a delivery rate of 28 percent per embryo transfer procedure after PGD in women whose mean age was 33 years [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/24\">",
"       24",
"      </a>",
"      ]. By comparison, a United States database reported the percentage of transfers resulting in live births ranged from 45.9 percent for women under age 35 to 27 percent for women aged 38 to 40 years [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fetal anomalies &mdash; The rate of fetal anomalies is not higher than with ART alone [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/35-42\">",
"       35-42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Postnatal development &mdash; Although data are limited, two year-olds conceived after",
"      <span class=\"nowrap\">",
"       PGD/PGS",
"      </span>",
"      show similar mental and psychomotor developmental outcomes to children conceived after ICSI or naturally [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23431/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preimplantation genetic diagnosis (PGD) is performed in couples known to be at increased risk of having a child with a specific heritable disorder. The goal is to establish an unaffected pregnancy. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Assisted reproductive technology (in vitro fertilization with or without intracytoplasmic sperm injection) is required even though many patients who undergo PGD have no known difficulties conceiving a pregnancy. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Reasons couples choose to undergo PGD'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      DNA for analysis is obtained from a polar body, one or two blastomeres obtained from the 6 to 9 cell mass day 3 after fertilization, or trophectoderm cells from a blastocyst on day 5 after fertilization. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Obtaining DNA for analysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Polymerase chain reaction (PCR) is used to test for gene defects and fluorescence in situ hybridization (FISH) is used to test for chromosomal abnormalities. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Genetic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Couples choose PGD to avoid terminating a pregnancy with a fetus affected by, or at risk for, a severe debilitating disease; to reduce the risk of recurrent pregnancy loss in individuals who carry balanced chromosomal translocations; to increase the parents' chances of having an HLA compatible offspring; and for medically-indicated sex selection. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Reasons couples choose to undergo PGD'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is a small but nonzero rate of false positive and false negative results. Therefore, chorionic villus biopsy or genetic amniocentesis is recommended to confirm PGD findings. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Counseling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PGD may decrease the chance of achieving pregnancy and live birth below that with natural conception, but there does not appear to be any long-term harms to offspring. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Safety'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/1\">",
"      Practice Committee of the Society for Assisted Reproductive Technology, Practice Committee of the American Society for Reproductive Medicine. Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril 2007; 88:1497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/2\">",
"      Cieslak-Janzen J, Tur-Kaspa I, Ilkevitch Y, et al. Multiple micromanipulations for preimplantation genetic diagnosis do not affect embryo development to the blastocyst stage. Fertil Steril 2006; 85:1826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/3\">",
"      Handyside AH, Pattinson JK, Penketh RJ, et al. Biopsy of human preimplantation embryos and sexing by DNA amplification. Lancet 1989; 1:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/4\">",
"      Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 1990; 344:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/5\">",
"      Boada M, Carrera M, De La Iglesia C, et al. Successful use of a laser for human embryo biopsy in preimplantation genetic diagnosis: report of two cases. J Assist Reprod Genet 1998; 15:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/6\">",
"      Clement-Sengewald A, Buchholz T, Sch&uuml;tze K, et al. Noncontact, laser-mediated extraction of polar bodies for prefertilization genetic diagnosis. J Assist Reprod Genet 2002; 19:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/7\">",
"      Verlinsky Y, Rechitsky S, Verlinsky O, et al. Prepregnancy testing for single-gene disorders by polar body analysis. Genet Test 1999; 3:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/8\">",
"      Verlinsky Y, Rechitsky S, Verlinsky O, et al. Preimplantation diagnosis for sonic hedgehog mutation causing familial holoprosencephaly. N Engl J Med 2003; 348:1449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/9\">",
"      Verlinsky Y, Rechitsky S, Cieslak J, et al. Preimplantation diagnosis of single gene disorders by two-step oocyte genetic analysis using first and second polar body. Biochem Mol Med 1997; 62:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/10\">",
"      Goossens V, De Rycke M, De Vos A, et al. Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod 2008; 23:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/11\">",
"      Carson SA, Gentry WL, Smith AL, Buster JE. Trophectoderm microbiopsy in murine blastocysts: comparison of four methods. J Assist Reprod Genet 1993; 10:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/12\">",
"      Sermon K, Van Steirteghem A, Liebaers I. Preimplantation genetic diagnosis. Lancet 2004; 363:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/13\">",
"      Veiga A, Sandalinas M, Benkhalifa M, et al. Laser blastocyst biopsy for preimplantation diagnosis in the human. Zygote 1997; 5:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/14\">",
"      Sampson JE, Ouhibi N, Lawce H, et al. The role for preimplantation genetic diagnosis in balanced translocation carriers. Am J Obstet Gynecol 2004; 190:1707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/15\">",
"      Kyu Lim C, Hyun Jun J, Mi Min D, et al. Efficacy and clinical outcome of preimplantation genetic diagnosis using FISH for couples of reciprocal and Robertsonian translocations: the Korean experience. Prenat Diagn 2004; 24:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/16\">",
"      Mackie Ogilvie C, Scriven PN. Preimplantation genetic diagnosis (PGD) for reciprocal translocations. Prenat Diagn 2004; 24:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/17\">",
"      Musters AM, Twisk M, Leschot NJ, et al. Perspectives of couples with high risk of transmitting genetic disorders. Fertil Steril 2010; 94:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/18\">",
"      Munn&eacute; S, Sandalinas M, Escudero T, et al. Outcome of preimplantation genetic diagnosis of translocations. Fertil Steril 2000; 73:1209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/19\">",
"      Verlinsky Y, Tur-Kaspa I, Cieslak J, et al. Preimplantation testing for chromosomal disorders improves reproductive outcome of poor-prognosis patients. Reprod Biomed Online 2005; 11:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/20\">",
"      Fischer J, Colls P, Escudero T, Munn&eacute; S. Preimplantation genetic diagnosis (PGD) improves pregnancy outcome for translocation carriers with a history of recurrent losses. Fertil Steril 2010; 94:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/21\">",
"      Stephenson MD, Sierra S. Reproductive outcomes in recurrent pregnancy loss associated with a parental carrier of a structural chromosome rearrangement. Hum Reprod 2006; 21:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/22\">",
"      Verlinsky Y, Rechitsky S, Schoolcraft W, et al. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA 2001; 285:3130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/23\">",
"      Amor DJ, Cameron C. PGD gender selection for non-Mendelian disorders with unequal sex incidence. Hum Reprod 2008; 23:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/24\">",
"      Goossens V, Harton G, Moutou C, et al. ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. Hum Reprod 2009; 24:1786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/25\">",
"      Committee on Ethics, American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 360: Sex selection. Obstet Gynecol 2007; 109:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/26\">",
"      Sex selection and preimplantation genetic diagnosis. The Ethics Committee of the American Society of Reproductive Medicine. Fertil Steril 1999; 72:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/27\">",
"      Wilton L, Thornhill A, Traeger-Synodinos J, et al. The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod 2009; 24:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/28\">",
"      Navidi W, Arnheim N. Using PCR in preimplantation genetic disease diagnosis. Hum Reprod 1991; 6:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/29\">",
"      Rechitsky S, Verlinsky O, Amet T, et al. Reliability of preimplantation diagnosis for single gene disorders. Mol Cell Endocrinol 2001; 183 Suppl 1:S65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/30\">",
"      Hussey ND, Davis T, Hall JR, et al. Preimplantation genetic diagnosis for beta-thalassaemia using sequencing of single cell PCR products to detect mutations and polymorphic loci. Mol Hum Reprod 2002; 8:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/31\">",
"      Lewis CM, Pin&ecirc;l T, Whittaker JC, Handyside AH. Controlling misdiagnosis errors in preimplantation genetic diagnosis: a comprehensive model encompassing extrinsic and intrinsic sources of error. Hum Reprod 2001; 16:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/32\">",
"      Gleicher N, Weghofer A, Barad D. Preimplantation genetic screening: \"established\" and ready for prime time? Fertil Steril 2008; 89:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/33\">",
"      Cohen J, Wells D, Munn&eacute; S. Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril 2007; 87:496.",
"     </a>",
"    </li>",
"    <li>",
"     www.cdc.gov (accessed May 27, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/35\">",
"      Strom CM, Levin R, Strom S, et al. Neonatal outcome of preimplantation genetic diagnosis by polar body removal: the first 109 infants. Pediatrics 2000; 106:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/36\">",
"      Harper JC, de Die-Smulders C, Goossens V, et al. ESHRE PGD consortium data collection VII: cycles from January to December 2004 with pregnancy follow-up to October 2005. Hum Reprod 2008; 23:741.",
"     </a>",
"    </li>",
"    <li>",
"     Verlinsky, Y, Kuliev A. An Illustration Textbook and Reference for Clinicians: An Atlas of Preimplantation Genetic Diagnosis, Parthenon Publishing, New York 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/38\">",
"      International Working Group on Preimplantation Genetics. Tenth anniversary of preimplantation genetic diagnosis. J Assist Reprod Genet 2001; 18:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/39\">",
"      Ginsberg, N, Cieslak J, Rechitsky S, et al. Clinical outcome following PGD in one large center. Reprod BioMed Online 2002; 4 (suppl 2, abs O-47):31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/40\">",
"      Verlinsky Y, Cohen J, Munne S, et al. Over a decade of experience with preimplantation genetic diagnosis: a multicenter report. Fertil Steril 2004; 82:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/41\">",
"      Fischer, J, Escudero T, Chen S, et al. Obstetric outcome of 100 cycles of PGD of translocations and other structural abnormalities. Reprod Biomed Online 2002; 4 (suppl 2, abs O-37):26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/42\">",
"      Desmyttere S, De Schepper J, Nekkebroeck J, et al. Two-year auxological and medical outcome of singletons born after embryo biopsy applied in preimplantation genetic diagnosis or preimplantation genetic screening. Hum Reprod 2009; 24:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23431/abstract/43\">",
"      Nekkebroeck J, Bonduelle M, Desmyttere S, et al. Mental and psychomotor development of 2-year-old children born after preimplantation genetic diagnosis/screening. Hum Reprod 2008; 23:1560.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6783 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A392849A5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23431=[""].join("\n");
var outline_f22_56_23431=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OBTAINING DNA FOR ANALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Polar body biopsy (PBB)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Blastomere biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Blastocyst biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      GENETIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Limitations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      REASONS COUPLES CHOOSE TO UNDERGO PGD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Unable or unwilling to undergo pregnancy termination of an affected fetus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Reduce high risk of recurrent pregnancy loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Increase chances of giving birth to a child with a compatible HLA type for stem cell therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Preimplantation sex selection to avoid sex-linked disorders in offspring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Avoid passing a suspected but unconfirmed autosomal dominant disease to offspring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      COUNSELING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SAFETY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6783\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6783|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/61/27606\" title=\"figure 1\">",
"      Principles of polar body biopsy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/47/11002?source=related_link\">",
"      Collection and storage of umbilical cord blood for hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=related_link\">",
"      Cytogenetic and molecular genetic diagnostic tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37770?source=related_link\">",
"      In vitro fertilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15546?source=related_link\">",
"      Intracytoplasmic sperm injection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/54/13159?source=related_link\">",
"      Polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/36/29256?source=related_link\">",
"      Techniques for preimplantation sex selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/2/7208?source=related_link\">",
"      Use of array comparative genomic hybridization (aCGH) in obstetrics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_56_23432="Vitamin K and the synthesis of gamma carboxyglutamic acid";
var content_f22_56_23432=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Vitamin K and the synthesis of gamma carboxyglutamic acid",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/56/23432/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/56/23432/contributors\">",
"     Bruce Furie, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/56/23432/contributors\">",
"     Beth A Bouchard, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/56/23432/contributors\">",
"     Barbara C Furie, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/56/23432/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/56/23432/contributors\">",
"     Lawrence LK Leung, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/56/23432/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/56/23432/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/56/23432/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin K is a cofactor for the enzymatic conversion of glutamic acid (Glu) residues to gamma-carboxyglutamic acid (Gla) in vitamin K-dependent proteins, via the endoplasmic reticulum resident vitamin K-dependent gamma-glutamyl carboxylase. This carboxylase activity is found in essentially all mammalian tissues and its reaction product, Gla, has been observed in both vertebrates and invertebrates; both play an important biological role in protein function [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The vitamin K-dependent biosynthesis of Gla will be discussed here. The functions of Gla, with special emphasis on the vitamin K-dependent proteins involved in the regulation of blood coagulation, and an overview of the coagulation cascade are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/32/20999?source=see_link\">",
"     \"Vitamin K, gamma carboxyglutamic acid, and the function of coagulation and other proteins\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/35/27194?source=see_link\">",
"     \"Overview of hemostasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACKGROUND AND HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin K and its association with blood coagulation were initially described in the 1920s and 1930s, following investigation of a hemorrhagic disease of cattle caused by ingestion of spoiled sweet clover [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/2\">",
"     2",
"    </a>",
"    ]. Since then, a number of observations, which will be discussed in detail below, have improved our understanding of the biological role of vitamin K [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Discovery of vitamin K antagonists and their introduction as pharmacologic agents for anticoagulation (ie, the coumarins) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Discovery of Gla in blood clotting proteins [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/5,6\">",
"       5,6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Identification of Gla as an amino acid that confers metal binding properties on proteins, a requirement for protein-membrane interaction [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/7,8\">",
"       7,8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Detection of an enzymatic activity (ie, the vitamin K-dependent gamma-glutamyl carboxylase) that catalyzes the incorporation of CO2 into glutamic acid to form Gla [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Identification of an intervening sequence (the propeptide) between the signal peptide and the mature vitamin K-dependent protein [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Discovery of the requirement for [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/10\">",
"       10",
"      </a>",
"      ] and the sufficiency of [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/11\">",
"       11",
"      </a>",
"      ] the gamma-carboxylation recognition site within the propeptide in directing synthesis of gamma-carboxyglutamic acid on the adjacent Gla domain of the precursor protein.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional advances include purification and cloning of the vitamin K-dependent carboxylase [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]; determination of the three-dimensional structure of the Gla domain of prothrombin and observation of an internal carboxylate-calcium network [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/14\">",
"     14",
"    </a>",
"    ]; the proposal of a mechanism of vitamin K-mediated enhancement of carboxylase action [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/15\">",
"     15",
"    </a>",
"    ]; and regulation of enzymatic vitamin K epoxidase activity by glutamate containing substrate [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     BIOSYNTHESIS OF GAMMA-CARBOXYGLUTAMIC ACID",
"    </span>",
"    &nbsp;&mdash;&nbsp;The requirement for vitamin K as an enzyme cofactor is unique to the vitamin K-dependent gamma-glutamyl carboxylase and the biosynthesis of gamma-carboxyglutamic acid (Gla). The mechanism by which vitamin K participates as a cofactor with the carboxylase is incompletely understood. The most attractive hypothesis is that an activated species of vitamin K abstracts a hydrogen from the gamma-carbon of Glu residues on specific proteins (factors VII, IX, X, and prothrombin; proteins S and C; and, in bone, osteocalcin [bone Gla protein] and matrix Gla protein), followed by transformation of the vitamin K intermediate to an epoxide. Carbon dioxide is subsequently added to the gamma-carbon of glutamic acid, utilizing the carboxylase activity of gamma-glutamyl carboxylase, to form Gla (",
"    <a class=\"graphic graphic_figure graphicRef61632 \" href=\"UTD.htm?39/9/40094\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based on a nonenzymatic model [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/15\">",
"     15",
"    </a>",
"    ], a \"base strength amplification mechanism\" has been proposed to explain the conversion of the weak base form of vitamin K (vitamin KH2) into an oxygenated intermediate (the alkoxide) of sufficient basicity to abstract a hydrogen from the gamma-carbon of Glu (",
"    <a class=\"graphic graphic_figure graphicRef61632 \" href=\"UTD.htm?39/9/40094\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/15\">",
"     15",
"    </a>",
"    ]. It was initially proposed that a free cysteine in the gamma-glutamyl carboxylase was responsible for deprotonation of vitamin KH2, a hypothesis that is supported by numerous publications [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/18-28\">",
"     18-28",
"    </a>",
"    ]. However, other studies suggest that the role of a free cysteine residue in carboxylation is uncertain, and implicate two lysine residues in the gamma-glutamyl carboxylase as important for catalysis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gamma-glutamyl carboxylase has two actions: it promotes the formation of Gla on the Glu residues; and it promotes the formation of the highly reactive alkoxide which then collapses into the epoxide form of vitamin K&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/16,18,31\">",
"     16,18,31",
"    </a>",
"    ]. Thus, under normal conditions, for each molecule of Gla generated, one molecule of vitamin K epoxide is also formed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The short-lived highly reactive alkoxide is potentially toxic, and it would be undesirable for it to be generated in the absence of Glu residues. Evidence indicates that no highly reactive vitamin K intermediate is generated by the carboxylase until a carboxylase substrate is bound to the enzyme and converts its vitamin K epoxidase function to an active state [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/16\">",
"     16",
"    </a>",
"    ]. The epoxide is then recycled back to vitamin KH2 via a vitamin K reductase (see below).",
"   </p>",
"   <p>",
"    The propeptide region of the vitamin K-dependent proteins functions as a recognition sequence, binding the carboxylase to its substrate on the adjacent glutamic acid rich (Gla) domain (see below) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. It also stimulates gamma-glutamyl carboxylation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     RECYCLING OF VITAMIN K",
"    </span>",
"    &nbsp;&mdash;&nbsp;In its naturally occurring form, vitamin K is in the quinone oxidation state and must be reduced to the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/59/36788?source=see_link\">",
"     hydroquinone",
"    </a>",
"    form (vitamin KH2), the active cofactor for the vitamin K-dependent carboxylase. The enzyme responsible for this conversion is known as vitamin K epoxide reductase (VKOR) because it also reduces the vitamin K epoxide formed during the carboxylation reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/35\">",
"     35",
"    </a>",
"    ]. Therapeutic doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , which shares a common ring structure with vitamin K (",
"    <a class=\"graphic graphic_figure graphicRef66755 \" href=\"UTD.htm?39/17/40220\">",
"     figure 2",
"    </a>",
"    ), inhibit this reductase, resulting in insufficient generation of vitamin K hydroquinone to support full carboxylation and therefore full function of the vitamin K-dependent proteins of blood coagulation.",
"   </p>",
"   <p>",
"    The gene encoding VKOR resides on chromosome 16 and encodes a protein of 163 amino acids [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. VKOR is effective at low concentrations of vitamin K epoxide and vitamin K quinone and is the physiologically important enzyme for recycling vitamin K [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Homologs of VKOR have been identified in a variety of organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. Like VKOR, all the homologs contain an active site CXXC motif as well as an additional pair of cysteines that are conserved. Bacterial VKOR homologs catalyze disulfide bond formation in secreted proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/42\">",
"     42",
"    </a>",
"    ]. The reducing equivalents required by the bacterial VKOR are provided by periplasmic thioredoxin-like proteins or by a thioredoxin-like domain fused to the VKOR domain. Reducing equivalents required for conversion of vitamin K quinone or epoxide to the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/59/36788?source=see_link\">",
"     hydroquinone",
"    </a>",
"    by mammalian VKOR are provided by endoplasmic reticulum thioredoxin-like proteins. Determination of the crystal structure of a naturally occurring bacterial VKOR-thioredoxin domain fusion protein has suggested an electron transfer pathway that could apply to all VKOR homologs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/43\">",
"     43",
"    </a>",
"    ]. Newly synthesized proteins in the periplasm or endoplasmic reticulum reduce the CXXC motif of a thioredoxin-like protein, which in turn reduces a conserved disulfide bridge in a loop of VKOR. The loop cysteines reduce the CXXC motif of VKOR and finally the disulfide in this CXXC motif is reestablished by reduction of a quinone [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/43\">",
"     43",
"    </a>",
"    ]. In mammalian systems, TMX, an endoplasmic reticulum membrane anchored thioredoxin-like protein, is the likely source of the reducing equivalents required for reduction of the epoxide and quinone by VKOR [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A second enzyme, DT-diaphorase, an NAD(P)H dehydrogenase, reduces the quinone form of vitamin K but not vitamin K epoxide [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/35\">",
"     35",
"    </a>",
"    ]. This enzyme requires high concentrations of vitamin K and probably does not play a role in recycling at physiologic tissue concentrations of vitamin K [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/38\">",
"     38",
"    </a>",
"    ]. It may, however, be important when vitamin K, in the quinone form, is used to overcome warfarin intoxication.",
"   </p>",
"   <p>",
"    Vitamin K epoxide is not detectable in the plasma of normal subjects, even after a pharmacologic dose of 10 mg of vitamin K [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/45\">",
"     45",
"    </a>",
"    ]. However, it is measurable following the administration of warfarin [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. The finding in warfarin-treated patients of a significant positive correlation between the INR and plasma vitamin K epoxide concentrations suggests that the latter reflects the pharmacodynamic activity of warfarin in anticoagulated patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Mutations and polymorphisms of the VKOR complex",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations of a protein in the VKOR complex have been described in a number of families with deficiency of the vitamin K-dependent coagulation proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/49-52\">",
"     49-52",
"    </a>",
"    ]. Consanguinity was present in one family. The defect was corrected by supplementation with vitamin K in a number of these families, and partially corrected in another [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/21/16730?source=see_link&amp;anchor=H28#H28\">",
"     \"Rare (recessively inherited) coagulation disorders\", section on 'Multiple vitamin K-dependent factor deficiencies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Hereditary warfarin resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Missense mutations within the gene for one member of this complex, vitamin K epoxide reductase complex subunit 1 (VKORC1), have been proposed to be involved in resistance to coumarin-type anticoagulant drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/36,53-56\">",
"     36,53-56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, common polymorphisms within the VKORC1 gene appear to modulate the mean daily dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    required to acquire target anticoagulation intensity, and may be associated with increased risk for arterial vascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42266?source=see_link&amp;anchor=H10#H10\">",
"     \"Therapeutic use of warfarin\", section on 'Genetic interactions'",
"    </a>",
"    .) A discussion of other factors that affect warfarin dosing can be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42266?source=see_link&amp;anchor=H25#H25\">",
"     \"Therapeutic use of warfarin\", section on 'Warfarin resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     THE GAMMA-CARBOXYLATION RECOGNITION SEQUENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The propeptides of the vitamin K-dependent proteins contain a gamma-carboxylation recognition site [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. In the vitamin K-dependent coagulation proteins (factors VII, IX, X, prothrombin) and regulatory proteins (proteins S and C), the recognition site is within the propeptide region; in contrast, the gamma-carboxylation recognition site resides within the mature protein sequence itself in matrix Gla protein [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The amino acids of this recognition site bind directly to the vitamin K-dependent carboxylase [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/59\">",
"     59",
"    </a>",
"    ]. Although no consensus sequence prevails in the carboxylation recognition sites, these sites are best defined by a Z-F-Z-X-X-X-X-A motif, where Z is an aliphatic hydrophobic residue (isoleucine, valine, or leucine), F is phenylalanine, A is alanine, and X is any amino acid. Phenylalanine at residue 16 is preferred in carboxylase substrates, but leucine, valine, and lysine at this position also support carboxylation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Disruption of the carboxylation recognition site in the propeptide region of factor IX yields a final protein that either lacks or is deficient in Gla [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/10\">",
"     10",
"    </a>",
"    ]. Thus, this recognition site is required for gamma-carboxylation to occur. It is most likely that this region of the blood coagulation protein precursor docks with the membrane-bound carboxylase, bringing the active site of the carboxylase in close proximity to the substrate Glu residues on the precursor form of the vitamin K-dependent proteins. There is no evidence that the amino acid sequence or three-dimensional structural elements in the immediate vicinity of the Glu residues contribute significantly to the recognition of the protein substrate by the carboxylase [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To test this hypothesis concerning the function of the recognition site, a prothrombin",
"    <span class=\"nowrap\">",
"     propeptide/thrombin",
"    </span>",
"    chimera was constructed, which had the signal peptide and gamma-carboxylation recognition site-containing propeptide of prothrombin juxtaposed to a glutamate-rich C-terminal region of thrombin. Of the eight glutamic acids within the first 40 residues of the NH2-terminus of prothrombin adjacent to the propeptide, which are not normally gamma-carboxylated, at least seven underwent complete carboxylation when this chimeric protein was expressed in CHO cells.",
"   </p>",
"   <p>",
"    These results indicate that the prothrombin gamma-carboxylation recognition site on the propeptide is sufficient to direct carboxylation of adjacent Glu residues in the",
"    <span class=\"nowrap\">",
"     propeptide/thrombin",
"    </span>",
"    chimera by the carboxylase, without regard for the sequence context of the Glu substrate or structures defined by disulfide bonds. Thus, we hypothesize that any protein will undergo gamma-carboxylation if it meets the following criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The protein includes a gamma-carboxylation recognition site that interacts with the gamma-glutamyl carboxylase",
"     </li>",
"     <li>",
"      The protein is routed through the rough endoplasmic reticulum during biosynthesis",
"     </li>",
"     <li>",
"      The cell has the carboxylase enzyme associated with the rough endoplasmic reticulum",
"     </li>",
"     <li>",
"      There are Glu sites within 40 residues of the gamma-carboxylation recognition site",
"     </li>",
"     <li>",
"      Intracellular vitamin K is present",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Recognition site mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional factors may also be important for the carboxylation recognition site. As an example of the importance of alanine at position 10 as part of the carboxylation recognition site, an experimentally induced mutation at this site is associated with diminished gamma-carboxylation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/10,61,62\">",
"     10,61,62",
"    </a>",
"    ]. In addition, naturally occurring mutations of alanine 10 to threonine or valine in factor IX are associated with a marked increase in sensitivity to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    or phenprocoumon that is limited to the patient's factor IX activity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/62-65\">",
"     62-65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The phenotype, factor IX levels, and factor IX carboxylation of these patients with mutations at alanine 10 were all normal; however, there was a more marked reduction in factor IX levels than in other vitamin K-dependent proteins after exposure to a vitamin K antagonist. It is possible that, with a reduced affinity for the carboxylase, the mutant profactor IX may be at a kinetic disadvantage when the concentration of the other carboxylase substrate, reduced vitamin K, is limited by coumarin-induced inhibition of the recycling enzymes. In contrast, the other unaffected vitamin K-dependent proteins can still compete effectively for enzyme and cofactor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     VITAMIN K-DEPENDENT CARBOXYLASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vitamin K-dependent carboxylase is an integral membrane protein, requiring carbon dioxide, molecular oxygen, and the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/59/36788?source=see_link\">",
"     hydroquinone",
"    </a>",
"    form of vitamin K to convert Glu residues to Gla (",
"    <a class=\"graphic graphic_figure graphicRef61632 \" href=\"UTD.htm?39/9/40094\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/13,66\">",
"     13,66",
"    </a>",
"    ]. Molecular cloning of the human and bovine vitamin K-dependent carboxylase predicted a single chain protein of 758 amino acids with a molecular weight of about 94,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/13,67\">",
"     13,67",
"    </a>",
"    ]. The human carboxylase gene is localized on chromosome 2p12, and is encoded by 15 exons [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The known functional properties of this enzyme include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A carboxylase active site",
"     </li>",
"     <li>",
"      An epoxidase active site",
"     </li>",
"     <li>",
"      A propeptide binding site that allows substrate to attach and shares sequence similarity with the propeptide of the carboxylase substrate [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/69\">",
"       69",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A propeptide binding site that stimulates carboxylase and epoxidase activity",
"     </li>",
"     <li>",
"      A glutamate binding site [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/70\">",
"       70",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A vitamin K binding site",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations of the carboxylase gene have been described in a number of families, leading to a congenital bleeding disorder with deficiency of all vitamin K-dependent coagulation factors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/71-73\">",
"     71-73",
"    </a>",
"    ]. A similar defect has been found in the Devon Rex cat [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/74\">",
"     74",
"    </a>",
"    ] and mice carrying a null mutation of the carboxylase gene die at birth of massive intra-abdominal hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/75\">",
"     75",
"    </a>",
"    ]. In most of the affected humans and in cats, the activity of the vitamin K-dependent coagulation factors can be normalized by vitamin K supplementation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/49,74,76,77\">",
"     49,74,76,77",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/21/16730?source=see_link&amp;anchor=H28#H28\">",
"     \"Rare (recessively inherited) coagulation disorders\", section on 'Multiple vitamin K-dependent factor deficiencies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     INTRACELLULAR SITE OF GAMMA-CARBOXYLATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of anticarboxylase antibodies has confirmed the intracellular localization of the carboxylase in both the endoplasmic reticulum and the Golgi apparatus. Studies in Chinese hamster ovary cells expressing prothrombin showed that uncarboxylated proprothrombin is completely gamma-carboxylated in the endoplasmic reticulum [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/78\">",
"     78",
"    </a>",
"    ]. The carboxylated proprothrombin leaves the endoplasmic reticulum intact and is further processed in the Golgi apparatus to remove the propeptide.",
"   </p>",
"   <p>",
"    Prothrombin and the other gamma-carboxylated extracellular vitamin K-dependent proteins bind to acidic membranes in the presence of calcium ions. The question therefore arises as to the mechanism which prevents the fully gamma-carboxylated intracellular precursor vitamin K-dependent proteins, such as proprothrombin, from binding to endoplasmic reticular membranes during transit through the biosynthetic pathway. The calcium concentration in the endoplasmic reticulum is high, in contrast to the cytoplasm, and is sufficient to support protein-membrane interaction.",
"   </p>",
"   <p>",
"    Fully carboxylated profactor IX does not bind to membranes in the presence of calcium ions, whereas factor IX does [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23432/abstract/79\">",
"     79",
"    </a>",
"    ]. Thus, the propeptide attached to factor IX appears to prevent proper folding of the Gla domain, expression of the phospholipid binding site, and the interaction of profactor IX with membranes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reprinted and adapted with permission from The American Society of Hematology. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999; 93:1798.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26625679\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vitamin K-dependent carboxylase is an integral membrane protein, requiring carbon dioxide, molecular oxygen, and the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/59/36788?source=see_link\">",
"     hydroquinone",
"    </a>",
"    form of vitamin K to convert glutamic acid (Glu) residues to gamma-carboxyglutamic acid (Gla) (",
"    <a class=\"graphic graphic_figure graphicRef61632 \" href=\"UTD.htm?39/9/40094\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Vitamin K-dependent carboxylase'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gla confers metal binding properties on the vitamin K-dependent proteins. With the addition of calcium ions, these proteins undergo a structural transition that leads to exposure of a phospholipid binding site. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/32/20999?source=see_link&amp;anchor=H2#H2\">",
"       \"Vitamin K, gamma carboxyglutamic acid, and the function of coagulation and other proteins\", section on 'Function of gamma-carboxyglutamic acid'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For each molecule of Gla generated, one molecule of vitamin K epoxide is also formed. The epoxide is then recycled back to vitamin KH2 via a vitamin K reductase. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Recycling of vitamin K'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mutations of the carboxylase gene have been described, leading to a congenital bleeding disorder with deficiency of all vitamin K-dependent coagulation factors. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Mutations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/1\">",
"      Vermeer C, De Boer-Van den Berg MA. Vitamin K-dependent carboxylase. Haematologia (Budap) 1985; 18:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/2\">",
"      Roderick LM. A problem in the coagulation of the blood \"sweet clover\" disease of cattle. Am J Physiol 1931; 96:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/3\">",
"      Dam H. The antihemorrhagic vitamin of the chick. Occurrence and chemical nature. Nature 1935; 135:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/4\">",
"      Campbell HA, Link KP. Studies on the hemorrhagic sweet clover disease IV. The isolation and crystallization of the hemorrhagic agent. J Biol Chem 1941; 138:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/5\">",
"      Stenflo J, Fernlund P, Egan W, Roepstorff P. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci U S A 1974; 71:2730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/6\">",
"      Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin. J Biol Chem 1974; 249:6347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/7\">",
"      Esmon CT, Sadowski JA, Suttie JW. A new carboxylation reaction. The vitamin K-dependent incorporation of H-14-CO3- into prothrombin. J Biol Chem 1975; 250:4744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/8\">",
"      Sperling R, Furie BC, Blumenstein M, et al. Metal binding properties of gamma-carboxyglutamic acid. Implications for the vitamin K-dependent blood coagulation proteins. J Biol Chem 1978; 253:3898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/9\">",
"      Kurachi K, Davie EW. Isolation and characterization of a cDNA coding for human factor IX. Proc Natl Acad Sci U S A 1982; 79:6461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/10\">",
"      Jorgensen MJ, Cantor AB, Furie BC, et al. Recognition site directing vitamin K-dependent gamma-carboxylation resides on the propeptide of factor IX. Cell 1987; 48:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/11\">",
"      Furie BC, Ratcliffe JV, Tward J, et al. The gamma-carboxylation recognition site is sufficient to direct vitamin K-dependent carboxylation on an adjacent glutamate-rich region of thrombin in a propeptide-thrombin chimera. J Biol Chem 1997; 272:28258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/12\">",
"      Wu SM, Morris DP, Stafford DW. Identification and purification to near homogeneity of the vitamin K-dependent carboxylase. Proc Natl Acad Sci U S A 1991; 88:2236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/13\">",
"      Wu SM, Cheung WF, Frazier D, Stafford DW. Cloning and expression of the cDNA for human gamma-glutamyl carboxylase. Science 1991; 254:1634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/14\">",
"      Soriano-Garcia M, Padmanabhan K, de Vos AM, Tulinsky A. The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry 1992; 31:2554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/15\">",
"      Dowd P, Hershline R, Ham SW, Naganathan S. Vitamin K and energy transduction: a base strength amplification mechanism. Science 1995; 269:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/16\">",
"      Sugiura I, Furie B, Walsh CT, Furie BC. Propeptide and glutamate-containing substrates bound to the vitamin K-dependent carboxylase convert its vitamin K epoxidase function from an inactive to an active state. Proc Natl Acad Sci U S A 1997; 94:9069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/17\">",
"      Friedman PA, Shia MA, Gallop PM, Griep AE. Vitamin K-dependent gamma-carbon-hydrogen bond cleavage and nonmandatory concurrent carboxylation of peptide-bound glutamic acid residues. Proc Natl Acad Sci U S A 1979; 76:3126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/18\">",
"      Morris DP, Soute BA, Vermeer C, Stafford DW. Characterization of the purified vitamin K-dependent gamma-glutamyl carboxylase. J Biol Chem 1993; 268:8735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/19\">",
"      Mack DO, Suen ET, Girardot JM, et al. Soluble enzyme system for vitamin K-dependent carboxylation. J Biol Chem 1976; 251:3269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/20\">",
"      Friedman PA, Shia M. Some characteristics of a vitamin K-dependent carboxylating system from rat liver microsomes. Biochem Biophys Res Commun 1976; 70:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/21\">",
"      Suttie JW, Lehrman SR, Geweke LO, et al. Vitamin K-dependent carboxylase: requirements for carboxylation of soluble peptide and substrate specificity. Biochem Biophys Res Commun 1979; 86:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/22\">",
"      Canfield LM, Sinsky TA, Suttie JW. Vitamin K-dependent carboxylase: purification of the rat liver microsomal enzyme. Arch Biochem Biophys 1980; 202:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/23\">",
"      Canfield LM. Vitamin K-dependent oxygenase/carboxylase; differential inactivation by sulfhydryl reagents. Biochem Biophys Res Commun 1987; 148:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/24\">",
"      Bouchard BA, Furie B, Furie BC. Glutamyl substrate-induced exposure of a free cysteine residue in the vitamin K-dependent gamma-glutamyl carboxylase is critical for vitamin K epoxidation. Biochemistry 1999; 38:9517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/25\">",
"      Tie J, Wu SM, Jin D, et al. A topological study of the human gamma-glutamyl carboxylase. Blood 2000; 96:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/26\">",
"      Pudota BN, Miyagi M, Hallgren KW, et al. Identification of the vitamin K-dependent carboxylase active site: Cys-99 and Cys-450 are required for both epoxidation and carboxylation. Proc Natl Acad Sci U S A 2000; 97:13033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/27\">",
"      Bandyopadhyay PK, Garrett JE, Shetty RP, et al. gamma -Glutamyl carboxylation: An extracellular posttranslational modification that antedates the divergence of molluscs, arthropods, and chordates. Proc Natl Acad Sci U S A 2002; 99:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/28\">",
"      Tie JK, Mutucumarana VP, Straight DL, et al. Determination of disulfide bond assignment of human vitamin K-dependent gamma-glutamyl carboxylase by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Biol Chem 2003; 278:45468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/29\">",
"      Rishavy MA, Pudota BN, Hallgren KW, et al. A new model for vitamin K-dependent carboxylation: the catalytic base that deprotonates vitamin K hydroquinone is not Cys but an activated amine. Proc Natl Acad Sci U S A 2004; 101:13732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/30\">",
"      Tie JK, Jin DY, Loiselle DR, et al. Chemical modification of cysteine residues is a misleading indicator of their status as active site residues in the vitamin K-dependent gamma-glutamyl carboxylation reaction. J Biol Chem 2004; 279:54079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/31\">",
"      Kuliopulos A, Hubbard BR, Lam Z, et al. Dioxygen transfer during vitamin K dependent carboxylase catalysis. Biochemistry 1992; 31:7722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/32\">",
"      Wood GM, Suttie JW. Vitamin K-dependent carboxylase. Stoichiometry of vitamin K epoxide formation, gamma-carboxyglutamyl formation, and gamma-glutamyl-3H cleavage. J Biol Chem 1988; 263:3234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/33\">",
"      Knobloch JE, Suttie JW. Vitamin K-dependent carboxylase. Control of enzyme activity by the \"propeptide\" region of factor X. J Biol Chem 1987; 262:15334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/34\">",
"      Li S, Furie BC, Furie B, Walsh CT. The propeptide of the vitamin K-dependent carboxylase substrate accelerates formation of the gamma-glutamyl carbanion intermediate. Biochemistry 1997; 36:6384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/35\">",
"      Suttie JW. Vitamin K-dependent carboxylase. Annu Rev Biochem 1985; 54:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/36\">",
"      Rost S, Fregin A, Ivaskevicius V, et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004; 427:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/37\">",
"      Li T, Chang CY, Jin DY, et al. Identification of the gene for vitamin K epoxide reductase. Nature 2004; 427:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/38\">",
"      Wallin R, Martin LF. Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo. Biochem J 1987; 241:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/39\">",
"      Spohn G, Kleinridders A, Wunderlich FT, et al. VKORC1 deficiency in mice causes early postnatal lethality due to severe bleeding. Thromb Haemost 2009; 101:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/40\">",
"      Goodstadt L, Ponting CP. Vitamin K epoxide reductase: homology, active site and catalytic mechanism. Trends Biochem Sci 2004; 29:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/41\">",
"      Singh AK, Bhattacharyya-Pakrasi M, Pakrasi HB. Identification of an atypical membrane protein involved in the formation of protein disulfide bonds in oxygenic photosynthetic organisms. J Biol Chem 2008; 283:15762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/42\">",
"      Dutton RJ, Boyd D, Berkmen M, Beckwith J. Bacterial species exhibit diversity in their mechanisms and capacity for protein disulfide bond formation. Proc Natl Acad Sci U S A 2008; 105:11933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/43\">",
"      Li W, Schulman S, Dutton RJ, et al. Structure of a bacterial homologue of vitamin K epoxide reductase. Nature 2010; 463:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/44\">",
"      Schulman S, Wang B, Li W, Rapoport TA. Vitamin K epoxide reductase prefers ER membrane-anchored thioredoxin-like redox partners. Proc Natl Acad Sci U S A 2010; 107:15027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/45\">",
"      Park BK, Choonara IA, Haynes BP, et al. Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins. Br J Clin Pharmacol 1986; 21:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/46\">",
"      Choonara IA, Malia RG, Haynes BP, et al. The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin. Br J Clin Pharmacol 1988; 25:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/47\">",
"      Cushman M, Booth SL, Possidente CJ, et al. The association of vitamin K status with warfarin sensitivity at the onset of treatment. Br J Haematol 2001; 112:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/48\">",
"      Kamali F, Edwards C, Butler TJ, Wynne HA. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation. Thromb Haemost 2000; 84:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/49\">",
"      Brenner B. Hereditary deficiency of vitamin K-dependent coagulation factors. Thromb Haemost 2000; 84:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/50\">",
"      Pauli RM, Lian JB, Mosher DF, Suttie JW. Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives. Am J Hum Genet 1987; 41:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/51\">",
"      Oldenburg J, von Brederlow B, Fregin A, et al. Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex. Thromb Haemost 2000; 84:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/52\">",
"      Marchetti G, Caruso P, Lunghi B, et al. Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency. J Thromb Haemost 2008; 6:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/53\">",
"      Bodin L, Horellou MH, Flaujac C, et al. A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance. J Thromb Haemost 2005; 3:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/54\">",
"      Loebstein R, Dvoskin I, Halkin H, et al. A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance. Blood 2007; 109:2477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/55\">",
"      Wilms EB, Touw DJ, Conemans JM, et al. A new VKORC1 allelic variant (p.Trp59Arg) in a patient with partial resistance to acenocoumarol and phenprocoumon. J Thromb Haemost 2008; 6:1224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/56\">",
"      Peoc'h K, Pruvot S, Gourmel C, et al. A new VKORC1 mutation leading to an isolated resistance to fluindione. Br J Haematol 2009; 145:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/57\">",
"      Wang Y, Zhang W, Zhang Y, et al. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 2006; 113:1615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/58\">",
"      Price PA, Fraser JD, Metz-Virca G. Molecular cloning of matrix Gla protein: implications for substrate recognition by the vitamin K-dependent gamma-carboxylase. Proc Natl Acad Sci U S A 1987; 84:8335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/59\">",
"      Hubbard BR, Ulrich MM, Jacobs M, et al. Vitamin K-dependent carboxylase: affinity purification from bovine liver by using a synthetic propeptide containing the gamma-carboxylation recognition site. Proc Natl Acad Sci U S A 1989; 86:6893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/60\">",
"      Tward JD, Furie BC, Bouchard BA, et al. Other amino acids than phenylalanine at position 16 in the carboxylation recognition site in the prothrombin propeptide can support gamma-carboxylation. Blood 1997; 90(Suppl 1):291a.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/61\">",
"      Huber P, Schmitz T, Griffin J, et al. Identification of amino acids in the gamma-carboxylation recognition site on the propeptide of prothrombin. J Biol Chem 1990; 265:12467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/62\">",
"      Chu K, Wu SM, Stanley T, et al. A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism. J Clin Invest 1996; 98:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/63\">",
"      Oldenburg J, Quenzel EM, Harbrecht U, et al. Missense mutations at ALA-10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy. Br J Haematol 1997; 98:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/64\">",
"      Oldenburg J, Kriz K, Wuillemin WA, et al. Genetic predisposition to bleeding during oral anticoagulant therapy: evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10). Thromb Haemost 2001; 85:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/65\">",
"      Kristensen SR. Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity. Blood 2002; 100:2676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/66\">",
"      Presnell SR, Stafford DW. The vitamin K-dependent carboxylase. Thromb Haemost 2002; 87:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/67\">",
"      Rehemtulla A, Roth DA, Wasley LC, et al. In vitro and in vivo functional characterization of bovine vitamin K-dependent gamma-carboxylase expressed in Chinese hamster ovary cells. Proc Natl Acad Sci U S A 1993; 90:4611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/68\">",
"      Kuo WL, Stafford DW, Cruces J, et al. Chromosomal localization of the gamma-glutamyl carboxylase gene at 2p12. Genomics 1995; 25:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/69\">",
"      Lin PJ, Jin DY, Tie JK, et al. The putative vitamin K-dependent gamma-glutamyl carboxylase internal propeptide appears to be the propeptide binding site. J Biol Chem 2002; 277:28584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/70\">",
"      Mutucumarana VP, Acher F, Straight DL, et al. A conserved region of human vitamin K-dependent carboxylase between residues 393 and 404 is important for its interaction with the glutamate substrate. J Biol Chem 2003; 278:46488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/71\">",
"      Brenner B, S&aacute;nchez-Vega B, Wu SM, et al. A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 1998; 92:4554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/72\">",
"      Spronk HM, Farah RA, Buchanan GR, et al. Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 2000; 96:3650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/73\">",
"      Rost S, Fregin A, Koch D, et al. Compound heterozygous mutations in the gamma-glutamyl carboxylase gene cause combined deficiency of all vitamin K-dependent blood coagulation factors. Br J Haematol 2004; 126:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/74\">",
"      Soute BA, Ulrich MM, Watson AD, et al. Congenital deficiency of all vitamin K-dependent blood coagulation factors due to a defective vitamin K-dependent carboxylase in Devon Rex cats. Thromb Haemost 1992; 68:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/75\">",
"      Zhu A, Sun H, Raymond RM Jr, et al. Fatal hemorrhage in mice lacking gamma-glutamyl carboxylase. Blood 2007; 109:5270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/76\">",
"      Mousallem M, Spronk HM, Sacy R, et al. Congenital combined deficiencies of all vitamin K-dependent coagulation factors. Thromb Haemost 2001; 86:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/77\">",
"      Soute BA, Jin DY, Spronk HM, et al. Characteristics of recombinant W501S mutated human gamma-glutamyl carboxylase. J Thromb Haemost 2004; 2:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/78\">",
"      Bristol JA, Ratcliffe JV, Roth DA, et al. Biosynthesis of prothrombin: intracellular localization of the vitamin K-dependent carboxylase and the sites of gamma-carboxylation. Blood 1996; 88:2585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23432/abstract/79\">",
"      Wasley LC, Rehemtulla A, Bristol JA, Kaufman RJ. PACE/furin can process the vitamin K-dependent pro-factor IX precursor within the secretory pathway. J Biol Chem 1993; 268:8458.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1318 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-218.28.111.102-3C51B1EE61-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23432=[""].join("\n");
var outline_f22_56_23432=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26625679\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACKGROUND AND HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      BIOSYNTHESIS OF GAMMA-CARBOXYGLUTAMIC ACID",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      RECYCLING OF VITAMIN K",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Mutations and polymorphisms of the VKOR complex",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Hereditary warfarin resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      THE GAMMA-CARBOXYLATION RECOGNITION SEQUENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Recognition site mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      VITAMIN K-DEPENDENT CARBOXYLASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      INTRACELLULAR SITE OF GAMMA-CARBOXYLATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26625679\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/1318\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1318|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/9/40094\" title=\"figure 1\">",
"      Vitamin K pathway",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/17/40220\" title=\"figure 2\">",
"      Vitamin K and warfarin",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/35/27194?source=related_link\">",
"      Overview of hemostasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/21/16730?source=related_link\">",
"      Rare (recessively inherited) coagulation disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42266?source=related_link\">",
"      Therapeutic use of warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/32/20999?source=related_link\">",
"      Vitamin K, gamma carboxyglutamic acid, and the function of coagulation and other proteins",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_56_23433="Molecular features of food allergens";
var content_f22_56_23433=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"20\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Molecular features of food allergens",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/56/23433/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/56/23433/contributors\">",
"     Heimo Breiteneder, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/56/23433/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/56/23433/contributors\">",
"     Scott H Sicherer, MD, FAAAAI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/56/23433/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/56/23433/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/56/23433/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the allergen-containing protein families, and consequently their individual members, possess characteristic molecular features that promote allergenicity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/1-5\">",
"     1-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A food allergen must possess certain structural and physicochemical properties that prevent it from being destroyed by the digestive process in order for a predisposed individual to become sensitized via exposure through the gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/6\">",
"     6",
"    </a>",
"    ]. These properties ensure that enough of the protein survives in a sufficiently intact form to be taken up by the gut and recognized by the mucosal immune system. Processing may alter the allergenicity of food [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, food allergens must possess the ability to induce a T helper cell type 2 (Th2)-biased, allergen-specific immune response via certain structural features of the allergen or association of the allergen with other molecules that act as adjuvants [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/9\">",
"     9",
"    </a>",
"    ]. Studies of the interaction of allergens and the innate immune system have highlighted the roles of pattern recognition receptors in initiating Th2-biased immune responses [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic reviews the structural and physicochemical features common to food allergens. The clinical features and cross-reactivity of food allergens and the pathogenesis of food allergy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2042?source=see_link\">",
"     \"Food allergens: Overview of clinical features and cross-reactivity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/42/43689?source=see_link\">",
"     \"Pathogenesis of food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A list of protein families that contain allergens can be accessed at",
"    <a class=\"external\" href=\"file://www.meduniwien.ac.at/allergens/allfam/\">",
"     file://www.meduniwien.ac.at/allergens/allfam/",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PROTEIN STABILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The conformational stability of an allergenic food protein is of high importance to its allergenicity. Stability of an allergenic protein describes its ability to maintain its original and allergenic three-dimensional structure despite being exposed to heat, harsh pH changes, and proteases. The term stability also encompasses the ability of a protein to refold to its native or near-native conformation during cooling after heat treatment. Several structural features are related to stability including the presence of disulfide bonds, glycosylation, and rheomorphism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Disulfide bonds",
"    </span>",
"    &nbsp;&mdash;&nbsp;The single most important structural feature of an allergenic food protein related to its stability is the presence of disulfide bonds that are formed by pairs of cysteine residues. Intrachain disulfide bonds link segments of single-chain proteins (eg, non-specific lipid transfer proteins) and interchain disulfide bonds link individual chains of multiple-chain proteins (eg, 2S albumins). Both types of disulfide bonds constrain the three-dimensional scaffold of a protein and protect it against denaturation by heat or protease digestion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Prolamin superfamily",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prolamin superfamily is the most important protein family for plant food allergens [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/1\">",
"     1",
"    </a>",
"    ]. This superfamily is characterized by the presence of a conserved cysteine skeleton [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/12\">",
"     12",
"    </a>",
"    ]. Many highly disulfide-bonded members of this superfamily are notable food allergens including 2S albumins, non-specific lipid transfer proteins, and the cereal inhibitors of trypsin and alpha-amylase. Besides the prolamin superfamily, the protein stability of several members of defense-related protein families (eg, class I chitinases and thaumatin-like proteins) is also based upon the presence of a number of disulfide bonds in their structures. Lists of allergens belonging to the various protein families can be viewed on the AllFam website [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      2S albumins &mdash; The 2S albumins are a major group of seed storage proteins that include seeds, tree nuts, and legumes. These compact molecules exhibit high thermostability and resistance to extreme pH values and proteolysis due to the presence of four conserved disulfide bonds. This stability was demonstrated in mustard seed [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/14\">",
"       14",
"      </a>",
"      ], rapeseed [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/15\">",
"       15",
"      </a>",
"      ], sesame seed [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/16\">",
"       16",
"      </a>",
"      ], sunflower seed [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/17\">",
"       17",
"      </a>",
"      ], Brazil nut [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/17-19\">",
"       17-19",
"      </a>",
"      ], and peanut [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/20,21\">",
"       20,21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Non-specific lipid transfer proteins (nsLTPs) &mdash; These proteins are structurally related to the 2S albumins. They play a role in plant defense mechanisms against bacteria and fungi, and possibly in the assembly of protective lipid layers, such as cutin, on exposed surfaces. These allergenic proteins also possess four disulfide bonds and are resistant to proteolysis, harsh pH changes, and thermal treatments [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/22\">",
"       22",
"      </a>",
"      ]. They are able to refold to their native structure on cooling. nsLTPs can survive conditions in the digestive tract as fully IgE-reactive molecules that retain the ability to trigger mast cells [",
"      <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The nsLTP found in peach is the major peach allergen, Pru p 3, and it is highly resistant to digestion by pepsin [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/24\">",
"     24",
"    </a>",
"    ]. Natural Pru p 3 purified from peach skin is heat-stable under acidic conditions, returning to its natural state upon cooling [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/25\">",
"     25",
"    </a>",
"    ]. Tri a 14, an nsLTP from wheat berries, displays high resistance to heat and digestive proteolysis, comparable to that of Pru p 3 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The IgE-binding capacity of the corn nsLTP, Zea m 14, remains unchanged after thermal treatments, even though its secondary structure is altered [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/27\">",
"     27",
"    </a>",
"    ]. Similarly, the cherry nsLTP, Pru av 3, shows a high resistance to digestion by pepsin and its IgE reactivity is not diminished after thermal processing [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/28\">",
"     28",
"    </a>",
"    ]. Heat stability has also been reported for the allergenic nsLTP, Cor a 8, from hazelnut [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Thaumatin-like proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thaumatin-like proteins (TLPs) belong to the family five of pathogenesis-related proteins. TLPs are involved in the resistance and response to fungal pathogens by inhibiting hyphal growth. The conformation of TLPs is stabilized by eight disulfide bonds [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/31\">",
"     31",
"    </a>",
"    ]. This extensive disulfide cross-linking renders zeamatin, a TLP from corn, highly resistant to proteolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Allergenic TLPs have been identified in various fruits, including apple [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/33,34\">",
"     33,34",
"    </a>",
"    ], cherry [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/35\">",
"     35",
"    </a>",
"    ], kiwi [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/36,37\">",
"     36,37",
"    </a>",
"    ], and grape [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/38\">",
"     38",
"    </a>",
"    ]. TLPs are produced by the grape plant during the ripening of the berry. They persist during the entire vinification process and are among the major proteins present in wine [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/39\">",
"     39",
"    </a>",
"    ]. Mal d 2, the TLP from apple, possesses remarkable stability to proteolysis and thermal treatments [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/34\">",
"     34",
"    </a>",
"    ]. The allergen retains its full IgE-binding capacity after two hours each of gastric and duodenal digestion. The heat-induced denaturation of the allergenic TLP from kiwi fruit, Act d 2, under acidic conditions is fully reversible, and IgE-binding to this allergen is detectable in processed food products [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Chitinases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chitinases form a large group of antifungal proteins that degrade the polymer chitin, a structural component of insect exoskeletons and fungal cell walls. Class I chitinases of fruits are the only major class of allergenic chitinases. These chitinases possess an N-terminal cysteine rich domain. This highly conserved hevein domain binds chitin and is stabilized by four disulfide bridges. The main IgE-binding epitopes are located in this domain [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/40\">",
"     40",
"    </a>",
"    ]. Pers a 1, the allergenic class I chitinase from avocado, retains its ability to produce positive skin prick tests after gastric digestion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Other allergens with disulfide bonds",
"    </span>",
"    &nbsp;&mdash;&nbsp;The allergenic soybean Kunitz trypsin inhibitor is resistant to thermal and proteolytic denaturation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/42\">",
"     42",
"    </a>",
"    ]. Kiwellin (Act d 5) is an important kiwi allergen that contains an N-terminal cysteine rich domain [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/43\">",
"     43",
"    </a>",
"    ]. It is one of the three most abundant proteins present in kiwi fruit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Glycosylation",
"    </span>",
"    &nbsp;&mdash;&nbsp;N-glycosylation is a major modification of proteins in plant cells during their passage through the endoplasmic reticulum. Glycosylation affects the biologic properties of proteins. The correct glycosylation of proteins plays a pivotal role in their folding [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/44\">",
"     44",
"    </a>",
"    ] and increases their thermal and proteolytic stability [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/45-47\">",
"     45-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The immunologic activity and relevance of IgE antibodies directed to carbohydrate epitopes has been a matter of debate since the discovery of N-glycan specific IgE [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/48\">",
"     48",
"    </a>",
"    ]. About 20 percent or more of allergic patients generate specific antiglycan IgE. Although IgE-binding glycoproteins are widespread in pollens, foods, and insect venoms, their cross-reactive carbohydrate determinants (CCDs) do not appear to cause clinical symptoms in most patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/49\">",
"     49",
"    </a>",
"    ]. One exception is the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal). Alpha-gal specific IgE antibodies bind to a variety of mammalian allergens and are associated with delayed anaphylaxis after eating mammalian meat [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 7S seed storage globulins are frequently glycosylated, with one or two N-linked glycosylation sites located in the C-terminal domain. The allergen Ara h 1, the 7S globulin of peanut, possesses one consensus N-glycosylation site. The glycan moieties attached to Ara h 1 are a heterogeneous mixture of N-glycans [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/52\">",
"     52",
"    </a>",
"    ]. Vicilin and convicilin, both 7S globulins, are potential major allergens from pea seeds. Proteolytic fragments from vicilin are relevant IgE-binding pea components [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/53\">",
"     53",
"    </a>",
"    ]. N-glycosylation of the 7S globulin of pea increases its stability and resistance to chemical denaturation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Rheomorphic proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proteins that contain large regions of disordered structures are called rheomorphic [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Such proteins are dynamic. They adopt various secondary structures that are in equilibrium with each other. They resemble unfolded, denatured, or partially folded proteins. Consequently, rheomorphic proteins do not undergo sharp transitions from one conformational state to another on heating, and thus possess many potential thermostable epitopes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The term rheomorphic was first used to describe caseins, major cow's milk allergens [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/56\">",
"     56",
"    </a>",
"    ]. Another group of rheomorphic proteins are the cereal seed storage prolamins. These proteins possess remnants of the original conserved cysteine skeleton of the prolamin superfamily that has been disrupted by the insertion of a central domain consisting of repeated sequences of varying lengths, depending on the type of cereal prolamin [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/58\">",
"     58",
"    </a>",
"    ]. These repetitive sequences adopt rapidly interconverting beta-turn and beta-sheet secondary structures that tend to form aggregates linked by intermolecular beta-sheets. The formation of such structures renders the seed storage prolamins rather insoluble, although they are hydrophilic and bind water avidly. Cereal prolamins do not possess a compact globular structure, and thus do not undergo a distinct transition from a native to denatured state when exposed to heat.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     INTERACTION WITH MEMBRANES AND OTHER LIPID STRUCTURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several food allergens are able to associate with cell membranes and other lipid structures. Such interactions may increase allergen uptake in the gastrointestinal tract. These associations may also delay or inhibit proteolytic degradation of allergens, because the sections of protein embedded in the lipid structure are no longer accessible to proteases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     2S albumins",
"    </span>",
"    &nbsp;&mdash;&nbsp;2S albumins function primarily as seed storage proteins. However, other functions have been ascribed to them, including antifungal activity. This antifungal activity results from an interaction with, and permeabilization of fungal cellular membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. This ability to affect membrane permeability also may play a role in gastrointestinal processing.",
"   </p>",
"   <p>",
"    The allergenic 2S albumin from mustard interacts with phospholipid vesicles, causing both vesicle aggregation, mixing of lipids between vesicles, and vesicle leakage [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/61\">",
"     61",
"    </a>",
"    ]. The extracellular leaflet of intestinal brush border membranes contains greater amounts of acidic phospholipid bilayers compared with other plasma membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/62\">",
"     62",
"    </a>",
"    ]. Interactions with these lipid bilayers may affect the uptake and processing of 2S albumin allergens in the gastrointestinal tract, increasing their allergenic potential [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SFA-8, an allergenic 2S albumin of sunflower seeds, is known for its emulsification properties [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. The 2S albumin allergens from sesame seeds (Ses i 1) and Brazil nut (Ber e 1) can penetrate intestinal epithelial layers intact to sensitize the mucosal immune system or elicit an allergic response [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Alpha-lactalbumin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Albumins are the main proteins of plasma. They bind water, cations, fatty acids, hormones, bilirubin, and drugs. Their main function is to regulate the colloidal osmotic pressure of blood. Bovine alpha-lactalbumin, although present in milk in low quantities, is an important cow's milk allergen [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/66\">",
"     66",
"    </a>",
"    ]. Interactions between alpha-lactalbumin and phosphatidylcholine, a surfactant that is abundant in milk and is actively secreted by the stomach, slow the breakdown of the allergen during in vitro digestion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Non-specific lipid transfer proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;nsLTPs are also able to interact with lipid structures. This ability is implicit in their function to transfer lipids between donor and acceptor vesicles [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/68\">",
"     68",
"    </a>",
"    ]. An nsLTP from wheat inserts into lipid monolayers, which is a simplified model of biologic membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/69\">",
"     69",
"    </a>",
"    ]. Wheat nsLTP can bind two single chain lipids, suggesting that this protein may even form bridges between lipid structures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/70\">",
"     70",
"    </a>",
"    ]. Although the nsLTP from sunflower seeds is unable to stabilize an emulsion due to the rapid coalescence of oil droplets, it was shown to adsorb at air-oil interfaces [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/63\">",
"     63",
"    </a>",
"    ]. The physiologic importance of such interactions in relation to the allergenic potential of nsLTPs remains to be studied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Thaumatin-like proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many TLPs have been reported to inhibit the growth of fungal hyphae, including the apple allergen Mal d 2 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/33\">",
"     33",
"    </a>",
"    ] and the allergenic TLP from banana [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/71\">",
"     71",
"    </a>",
"    ]. The precise mechanism of this biologic activity is not clear, but it may result from permeabilization of fungal membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]. TLPs may also interact directly with the lipid bilayer of the fungal plasma membrane. This lipid bilayer is composed of sphingolipids, phospholipids, and sterols that occur in membranes of all living organisms. The membrane permeabilizing activity of linusitin, an antifungal TLP from flax seeds, depends upon membrane composition, and is amplified by increased content of negatively charged phospholipids and the presence of sterols [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     PR-10 proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major birch pollen allergen, Bet v 1, is a member of the ubiquitous PR-10 family of proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/75\">",
"     75",
"    </a>",
"    ]. Bet v 1-related allergens are found in a wide range of plant foods and generally cause only mild oral symptoms. However, there are reports of severe and anaphylactic reactions caused by Bet v 1-related allergens, such as Gly m 4 from soybean [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. Bet v 1 binding to membranes is accompanied by major structural rearrangements [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/78\">",
"     78",
"    </a>",
"    ]. This capability might provide a mechanism by which PR-10 proteins present in foods and still intact in the digestive tract, cross the mucosal lining and become internalized, thereby facilitating an allergic reaction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     LIGAND BINDING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain food allergens are able to bind nonallergenic organic compounds or ions as ligands, including glucocorticoids and a variety of lipid molecules. Ligand binding increases the stability of an allergen, thus enhancing its allergenic potential.",
"   </p>",
"   <p>",
"    Ionic ligands, such as metal ions, become part of the structure of a protein and are often deeply buried within the molecule. Ligand binding often results in reduced mobility of the polypeptide backbone. This leads to a decreased susceptibility to thermal and proteolytic denaturation, since many proteases require a certain flexibility of the substrate protein. The loss of a metal ion often disrupts the protein folding and leads to an increase in protein mobility, and in some instances, to a transition to a partially folded form. Some proteins possess a cavity or a tunnel into which the ligand fits, and others bind ligands through surface interactions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Non-specific lipid transfer proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;nsLTPs are able to bind lipid molecules in a tunnel that runs through the entire protein and is lined with hydrophobic residues. The size of the tunnel varies for different nsLTPs.",
"   </p>",
"   <p>",
"    Barley and wheat nsLTPs are able to bind a variety of fatty acids and phospholipids of differing lengths with high affinity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. Wheat nsLTP can bind a wide range of lipophilic molecules, including sphingolipids, prostaglandin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    , and other hydrophobic drugs, due to the high plasticity of the hydrophobic cavity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. Barley nsLTP can accommodate two lipid molecules, lying side by side within the tunnel [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/79\">",
"     79",
"    </a>",
"    ]. Disulfide bridges are essential for the existence of the cavity, whereas its plasticity depends upon both the hydrophobic residues lining the cavity and the C-terminal flexibility [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Structural features and ligand binding are both directly related to nsLTP stability. Grape nsLTP is unaltered after gastric digestion and a C-terminally trimmed fragment is produced by duodenal digestion. This fragment has the same in vitro and in vivo IgE reactivity as the intact protein. Inclusion of phosphatidylcholine protected the nsLTP to a limited extent against digestion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Parvalbumins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parvalbumins constitute a class of calcium-binding proteins characterized by the presence of several helix-loop-helix (EF-hand) motifs. The EF-hand motif consists of a 12-residue loop flanked on both sides by 12-residue alpha-helical domains. Parvalbumins possess three such EF-hand motifs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/85\">",
"     85",
"    </a>",
"    ], two of which are capable of binding calcium [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Parvalbumins can be subdivided into two distinct evolutionary lineages, alpha- and beta-parvalbumins, although their overall folds are very similar. Beta-parvalbumins are present in the white muscle of many fish species in relative high amounts and are generally allergenic. Loss of parvalbumin-bound calcium triggers large conformational changes and an associated loss of conformation dependent IgE epitopes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/87-89\">",
"     87-89",
"    </a>",
"    ]. Parvalbumins show a remarkable resistance to heat, denaturing chemicals, and proteases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/90\">",
"     90",
"    </a>",
"    ]. Sufficient IgE-reactive epitopes remain after cooking to trigger allergic reactions in susceptible individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Beta-lactoglobulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lipocalins are a diverse family of proteins comprising extracellular ligand-binding proteins with high specificity for small hydrophobic molecules [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/92\">",
"     92",
"    </a>",
"    ]. Beta-lactoglobulin, the major whey protein in milk of ruminants and many other mammals, is a cow's milk allergen that belongs to the lipocalin superfamily. It binds a diverse range of molecules, including retinol and its analogues,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    , saturated and unsaturated fatty acids, and aliphatic hydrocarbons [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relative resistance of beta-lactoglobulin to acid hydrolysis and protease degradation allows some of the protein to remain intact after digestion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/94\">",
"     94",
"    </a>",
"    ]. Heat treatment induces conformational changes in beta-lactoglobulin and increases its susceptibility to enzymatic digestion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/57\">",
"     57",
"    </a>",
"    ]. In addition, heat-induced denaturation of beta-lactoglobulin is associated with weaker binding of IgE from individuals with cow's milk allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     AGGREGATES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural tendency of certain proteins to form oligomers or aggregates of higher order or aggregation that is induced by food processing conditions most likely affects sensitization by enhancing immunogenicity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 7S and 11S globulin seed storage proteins of the cupin superfamily have a tendency to assemble into large structures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/1\">",
"     1",
"    </a>",
"    ]. They exist in an equilibrium of trimers and hexamers that are held together by noncovalent interactions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/97\">",
"     97",
"    </a>",
"    ]. Both 7S and 11S globulins are stable to heating. The cupin barrel is thought to remain intact with heat exposure. Unfolding of other regions with heating results in a loss of quaternary structure along with concomitant formation of large aggregates. These aggregates form flocculent precipitates when they become sufficiently large.",
"   </p>",
"   <p>",
"    At very high protein concentrations of 5 to 10 percent, similar to that found in food systems, the aggregates form heat-set gel networks [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/98-100\">",
"     98-100",
"    </a>",
"    ]. Heating most likely results in the formation of partially-folded molten globule structures that rapidly go on to form large aggregated structures, becoming kinetically trapped in unfolded states in the process. Beta-conglycinin, an allergenic 7S globulin of soybeans, forms thermally-induced aggregates [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     GLYCATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glycation describes the non-enzymatic bonding of sugar molecules to proteins or lipid molecules. The process, also called the Maillard reaction, involves sugars reacting with free amino groups on proteins to form Amadori compounds. These compounds may then rearrange to produce a range of adducts known as advanced glycation end products (AGE). AGEs form during thermal processing, particularly during the application of dry heating procedures such as roasting. They also slowly form over days and months as a consequence of the aging process of foods.",
"   </p>",
"   <p>",
"    Heating in either wet (eg, boiling) or dry processes (eg, frying) can denature",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    modify proteins. Glycation may underlie the different effects such processes have on the allergenicity of foods. As an example, glycation reactions may be responsible for the apparent increase in allergenic activity of peanuts following processes such as curing and roasting [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/101,102\">",
"     101,102",
"    </a>",
"    ]. Peanuts and tree nuts are often subjected to thermal processing at low water levels and high heat (eg, roasting), unlike soybean and lentils, which are usually boiled. Proteins become more thermostable in low-water systems, because protein denaturation requires the presence of water [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/103\">",
"     103",
"    </a>",
"    ]. The major peanut allergen Ara h 1 only unfolds after roasting peanuts to 140&ordm;C for 15 minutes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/104\">",
"     104",
"    </a>",
"    ]. Thermal treatment of Ara h 2, the 2S albumin from peanuts, in the presence of reactive carbohydrates induces a strong increase of its IgE binding activity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/105\">",
"     105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One potential mechanism of action for the enhanced T cell immunogenicity of AGEs was suggested in an in vitro murine study [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/106\">",
"     106",
"    </a>",
"    ]. OVA-specific CD4+ T cell activation was enhanced when myeloid dendritic cells (mDC) were cocultured with ovalbumin (OVA) with AGEs compared with native OVA or OVA thermally processed without glucose. mDC uptake of OVA with AGEs was mediated by scavenger receptor class A type I and II that target the MHC class II pathway.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     REPETITIVE STRUCTURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is possible that highly repetitive linear epitopes are to some degree unaffected by heat denaturation and partial proteolysis. Tropomyosins are a family of closely related proteins present in muscle and non-muscle cells [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/107\">",
"     107",
"    </a>",
"    ]. Tropomyosins contain a seven amino acid residue (\"heptad\") repeat [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/108\">",
"     108",
"    </a>",
"    ]. Most tropomyosins have an unbroken series of 40 continuous heptads. The major seafood allergens are heat stable, cross-reactive tropomyosins. Extracts from boiled Penaeus indicus shrimp were found to contain the allergenic tropomyosin Pen i 1, with unaltered allergenicity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/109\">",
"     109",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Repetitive structures are also a characteristic feature of many rheomorphic proteins. Cereal seed storage prolamins probably exhibit the most degenerate repetitive sequences. These are based upon several different short motifs that are rich in proline and glutamine and range from four to eight residues in length [",
"    <a class=\"abstract\" href=\"UTD.htm?22/56/23433/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Many of the allergen-containing protein families, and consequently their individual members, possess characteristic molecular features that promote allergenicity. Structural features in complete food allergens appear to provoke T helper cell type 2 (Th2)-biased immune responses in predisposed individuals by interacting with innate immune receptors. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The conformational stability of an allergenic food protein is important to its allergenicity. Several structural features are related to stability including the presence of disulfide bonds, glycosylation, and rheomorphism. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Protein stability'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Interactions with cell membranes and other lipid structures may increase allergen uptake in the gastrointestinal tract, and may also delay or inhibit proteolytic degradation of allergens. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Interaction with membranes and other lipid structures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Certain food allergens are able to bind nonallergenic organic compounds or ions as ligands. Ligand binding often results in a decreased susceptibility to thermal and proteolytic denaturation. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Ligand binding'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Aggregation that occurs naturally or is induced by food processing most likely affects sensitization by enhancing immunogenicity. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Aggregates'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Glycation reactions may be responsible for the apparent increase in allergenic activity of certain foods following processes such as roasting. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Glycation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Highly repetitive linear epitopes are to some degree unaffected by heat denaturation and partial proteolysis, and may also augment allergenicity. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Repetitive structures'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/1\">",
"      Breiteneder H, Radauer C. A classification of plant food allergens. J Allergy Clin Immunol 2004; 113:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/2\">",
"      Mills EN, Jenkins JA, Alcocer MJ, Shewry PR. Structural, biological, and evolutionary relationships of plant food allergens sensitizing via the gastrointestinal tract. Crit Rev Food Sci Nutr 2004; 44:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/3\">",
"      Jenkins JA, Griffiths-Jones S, Shewry PR, et al. Structural relatedness of plant food allergens with specific reference to cross-reactive allergens: an in silico analysis. J Allergy Clin Immunol 2005; 115:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/4\">",
"      Radauer C, Bublin M, Wagner S, et al. Allergens are distributed into few protein families and possess a restricted number of biochemical functions. J Allergy Clin Immunol 2008; 121:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/5\">",
"      Jenkins JA, Breiteneder H, Mills EN. Evolutionary distance from human homologs reflects allergenicity of animal food proteins. J Allergy Clin Immunol 2007; 120:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/6\">",
"      Breiteneder H, Clare Mills EN. Plant food allergens--structural and functional aspects of allergenicity. Biotechnol Adv 2005; 23:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/7\">",
"      Mills EN, Mackie AR. The impact of processing on allergenicity of food. Curr Opin Allergy Clin Immunol 2008; 8:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/8\">",
"      Nowak-Wegrzyn A, Fiocchi A. Rare, medium, or well done? The effect of heating and food matrix on food protein allergenicity. Curr Opin Allergy Clin Immunol 2009; 9:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/9\">",
"      Ruiter B, Shreffler WG. Innate immunostimulatory properties of allergens and their relevance to food allergy. Semin Immunopathol 2012; 34:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/10\">",
"      Minnicozzi M, Sawyer RT, Fenton MJ. Innate immunity in allergic disease. Immunol Rev 2011; 242:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/11\">",
"      Pulendran B, Artis D. New paradigms in type 2 immunity. Science 2012; 337:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/12\">",
"      Kreis M, Forde BG, Rahman S, et al. Molecular evolution of the seed storage proteins of barley, rye and wheat. J Mol Biol 1985; 183:499.",
"     </a>",
"    </li>",
"    <li>",
"     AllFam is a frequently updated database of allergen-containing protein families that is available on the web at www.meduniwien.ac.at/allergens/allfam/ (Accessed on February 11, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/14\">",
"      Dom&iacute;nguez J, Cuevas M, Ure&ntilde;a V, et al. Purification and characterization of an allergen of mustard seed. Ann Allergy 1990; 64:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/15\">",
"      Pantoja-Uceda D, Palomares O, Bruix M, et al. Solution structure and stability against digestion of rproBnIb, a recombinant 2S albumin from rapeseed: relationship to its allergenic properties. Biochemistry 2004; 43:16036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/16\">",
"      Moreno FJ, Maldonado BM, Wellner N, Mills EN. Thermostability and in vitro digestibility of a purified major allergen 2S albumin (Ses i 1) from white sesame seeds (Sesamum indicum L.). Biochim Biophys Acta 2005; 1752:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/17\">",
"      Murtagh GJ, Archer DB, Dumoulin M, et al. In vitro stability and immunoreactivity of the native and recombinant plant food 2S albumins Ber e 1 and SFA-8. Clin Exp Allergy 2003; 33:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/18\">",
"      Moreno FJ, Mellon FA, Wickham MS, et al. Stability of the major allergen Brazil nut 2S albumin (Ber e 1) to physiologically relevant in vitro gastrointestinal digestion. FEBS J 2005; 272:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/19\">",
"      Koppelman SJ, Nieuwenhuizen WF, Gaspari M, et al. Reversible denaturation of Brazil nut 2S albumin (Ber e1) and implication of structural destabilization on digestion by pepsin. J Agric Food Chem 2005; 53:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/20\">",
"      Suhr M, Wicklein D, Lepp U, Becker WM. Isolation and characterization of natural Ara h 6: evidence for a further peanut allergen with putative clinical relevance based on resistance to pepsin digestion and heat. Mol Nutr Food Res 2004; 48:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/21\">",
"      Lehmann K, Schweimer K, Reese G, et al. Structure and stability of 2S albumin-type peanut allergens: implications for the severity of peanut allergic reactions. Biochem J 2006; 395:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/22\">",
"      van Ree R. Clinical importance of non-specific lipid transfer proteins as food allergens. Biochem Soc Trans 2002; 30:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/23\">",
"      Asero R, Mistrello G, Roncarolo D, et al. Lipid transfer protein: a pan-allergen in plant-derived foods that is highly resistant to pepsin digestion. Int Arch Allergy Immunol 2000; 122:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/24\">",
"      Duffort OA, Polo F, Lombardero M, et al. Immunoassay to quantify the major peach allergen Pru p 3 in foodstuffs. Differential allergen release and stability under physiological conditions. J Agric Food Chem 2002; 50:7738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/25\">",
"      Gaier S, Marsh J, Oberhuber C, et al. Purification and structural stability of the peach allergens Pru p 1 and Pru p 3. Mol Nutr Food Res 2008; 52 Suppl 2:S220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/26\">",
"      Palacin A, Varela J, Quirce S, et al. Recombinant lipid transfer protein Tri a 14: a novel heat and proteolytic resistant tool for the diagnosis of baker's asthma. Clin Exp Allergy 2009; 39:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/27\">",
"      Pastorello EA, Pompei C, Pravettoni V, et al. Lipid-transfer protein is the major maize allergen maintaining IgE-binding activity after cooking at 100 degrees C, as demonstrated in anaphylactic patients and patients with positive double-blind, placebo-controlled food challenge results. J Allergy Clin Immunol 2003; 112:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/28\">",
"      Scheurer S, Lauer I, Foetisch K, et al. Strong allergenicity of Pru av 3, the lipid transfer protein from cherry, is related to high stability against thermal processing and digestion. J Allergy Clin Immunol 2004; 114:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/29\">",
"      Schocker F, L&uuml;ttkopf D, M&uuml;ller U, et al. IgE binding to unique hazelnut allergens: identification of non pollen-related and heat-stable hazelnut allergens eliciting severe allergic reactions. Eur J Nutr 2000; 39:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/30\">",
"      Schocker F, L&uuml;ttkopf D, Scheurer S, et al. Recombinant lipid transfer protein Cor a 8 from hazelnut: a new tool for in vitro diagnosis of potentially severe hazelnut allergy. J Allergy Clin Immunol 2004; 113:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/31\">",
"      Thompson CE, Fernandes CL, de Souza ON, et al. Molecular modeling of pathogenesis-related proteins of family 5. Cell Biochem Biophys 2006; 44:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/32\">",
"      Roberts WK, Selitrennikoff CP. Zeamatin, an antifungal protein from maize with membrane-permeabilizing activity. J Gen Microbiol 1990; 136:1771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/33\">",
"      Krebitz M, Wagner B, Ferreira F, et al. Plant-based heterologous expression of Mal d 2, a thaumatin-like protein and allergen of apple (Malus domestica), and its characterization as an antifungal protein. J Mol Biol 2003; 329:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/34\">",
"      Smole U, Bublin M, Radauer C, et al. Mal d 2, the thaumatin-like allergen from apple, is highly resistant to gastrointestinal digestion and thermal processing. Int Arch Allergy Immunol 2008; 147:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/35\">",
"      Fuchs HC, Bohle B, Dall'Antonia Y, et al. Natural and recombinant molecules of the cherry allergen Pru av 2 show diverse structural and B cell characteristics but similar T cell reactivity. Clin Exp Allergy 2006; 36:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/36\">",
"      Gavrovi��-Jankulovi�� M, ��Irkovi�� T, Vuckovi�� O, et al. Isolation and biochemical characterization of a thaumatin-like kiwi allergen. J Allergy Clin Immunol 2002; 110:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/37\">",
"      Bublin M, Radauer C, Knulst A, et al. Effects of gastrointestinal digestion and heating on the allergenicity of the kiwi allergens Act d 1, actinidin, and Act d 2, a thaumatin-like protein. Mol Nutr Food Res 2008; 52:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/38\">",
"      Pastorello EA, Farioli L, Pravettoni V, et al. Identification of grape and wine allergens as an endochitinase 4, a lipid-transfer protein, and a thaumatin. J Allergy Clin Immunol 2003; 111:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/39\">",
"      Flamini R, De Rosso M. Mass spectrometry in the analysis of grape and wine proteins. Expert Rev Proteomics 2006; 3:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/40\">",
"      D&igrave;az-Perales A, S&aacute;nchez-Monge R, Blanco C, et al. What is the role of the hevein-like domain of fruit class I chitinases in their allergenic capacity? Clin Exp Allergy 2002; 32:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/41\">",
"      D&iacute;az-Perales A, Blanco C, S&aacute;nchez-Monge R, et al. Analysis of avocado allergen (Prs a 1) IgE-binding peptides generated by simulated gastric fluid digestion. J Allergy Clin Immunol 2003; 112:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/42\">",
"      Roychaudhuri R, Sarath G, Zeece M, Markwell J. Stability of the allergenic soybean Kunitz trypsin inhibitor. Biochim Biophys Acta 2004; 1699:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/43\">",
"      Tamburrini M, Cerasuolo I, Carratore V, et al. Kiwellin, a novel protein from kiwi fruit. Purification, biochemical characterization and identification as an allergen*. Protein J 2005; 24:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/44\">",
"      Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science 2001; 291:2364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/45\">",
"      Wormald MR, Dwek RA. Glycoproteins: glycan presentation and protein-fold stability. Structure 1999; 7:R155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/46\">",
"      Wang C, Eufemi M, Turano C, Giartosio A. Influence of the carbohydrate moiety on the stability of glycoproteins. Biochemistry 1996; 35:7299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/47\">",
"      Opdenakker G, Rudd PM, Ponting CP, Dwek RA. Concepts and principles of glycobiology. FASEB J 1993; 7:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/48\">",
"      van Ree R. Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int Arch Allergy Immunol 2002; 129:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/49\">",
"      Altmann F. The role of protein glycosylation in allergy. Int Arch Allergy Immunol 2007; 142:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/50\">",
"      Commins SP, Satinover SM, Hosen J, et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol 2009; 123:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/51\">",
"      Commins SP, Platts-Mills TA. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol 2009; 124:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/52\">",
"      van Ree R, Cabanes-Macheteau M, Akkerdaas J, et al. Beta(1,2)-xylose and alpha(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. J Biol Chem 2000; 275:11451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/53\">",
"      Sanchez-Monge R, Lopez-Torrej&oacute;n G, Pascual CY, et al. Vicilin and convicilin are potential major allergens from pea. Clin Exp Allergy 2004; 34:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/54\">",
"      Pedrosa C, De Felice FG, Trisciuzzi C, Ferreira ST. Selective neoglycosylation increases the structural stability of vicilin, the 7S storage globulin from pea seeds. Arch Biochem Biophys 2000; 382:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/55\">",
"      Dunker AK, Lawson JD, Brown CJ, et al. Intrinsically disordered protein. J Mol Graph Model 2001; 19:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/56\">",
"      Holt C, Sawyer L. Caseins as rheomorphic proteins: interpretation of the primary and secondary structures of alpha S1 - beta- and kappa- caseins. J Chem Soc Farad Trans 1993; 89:2683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/57\">",
"      Morisawa Y, Kitamura A, Ujihara T, et al. Effect of heat treatment and enzymatic digestion on the B cell epitopes of cow's milk proteins. Clin Exp Allergy 2009; 39:918.",
"     </a>",
"    </li>",
"    <li>",
"     Shewry PR, Tatham AS. The characterisation, structures and evolutionary relationships of prolamins, Kluwer Academic Publishers, Dordrecht 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/59\">",
"      Terras FR, Schoofs HM, De Bolle MF, et al. Analysis of two novel classes of plant antifungal proteins from radish (Raphanus sativus L.) seeds. J Biol Chem 1992; 267:15301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/60\">",
"      Terras F, Schoofs H, Thevissen K, et al. Synergistic Enhancement of the Antifungal Activity of Wheat and Barley Thionins by Radish and Oilseed Rape 2S Albumins and by Barley Trypsin Inhibitors. Plant Physiol 1993; 103:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/61\">",
"      O&ntilde;aderra M, Monsalve RI, Manche&ntilde;o JM, et al. Food mustard allergen interaction with phospholipid vesicles. Eur J Biochem 1994; 225:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/62\">",
"      Zachowski A. Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J 1993; 294 ( Pt 1):1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/63\">",
"      Burnett GR, Rigby NM, Mills EN, et al. Characterization of the emulsification properties of 2S albumins from sunflower seed. J Colloid Interface Sci 2002; 247:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/64\">",
"      Pantoja-Uceda D, Shewry PR, Bruix M, et al. Solution structure of a methionine-rich 2S albumin from sunflower seeds: relationship to its allergenic and emulsifying properties. Biochemistry 2004; 43:6976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/65\">",
"      Moreno FJ, Rubio LA, Olano A, Clemente A. Uptake of 2S albumin allergens, Ber e 1 and Ses i 1, across human intestinal epithelial Caco-2 cell monolayers. J Agric Food Chem 2006; 54:8631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/66\">",
"      Wal JM. Cow's milk allergens. Allergy 1998; 53:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/67\">",
"      Moreno FJ, Mackie AR, Mills EN. Phospholipid interactions protect the milk allergen alpha-lactalbumin from proteolysis during in vitro digestion. J Agric Food Chem 2005; 53:9810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/68\">",
"      Kader JC. Lipid-transfer proteins: A puzzling family of plant proteins. Trends Plant Sci 1997; 2:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/69\">",
"      Subirade M, Salesse C, Marion D, P&eacute;zolet M. Interaction of a nonspecific wheat lipid transfer protein with phospholipid monolayers imaged by fluorescence microscopy and studied by infrared spectroscopy. Biophys J 1995; 69:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/70\">",
"      Douliez JP, Sy D, Vovelle F, Marion D. Interaction of surfactants and polymer-grafted lipids with a plant lipid transfer protein, LTP1. Langmuir 2002; 18:7309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/71\">",
"      Leone P, Menu-Bouaouiche L, Peumans WJ, et al. Resolution of the structure of the allergenic and antifungal banana fruit thaumatin-like protein at 1.7-A. Biochimie 2006; 88:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/72\">",
"      Vigers AJ, Roberts WK, Selitrennikoff CP. A new family of plant antifungal proteins. Mol Plant Microbe Interact 1991; 4:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/73\">",
"      Batalia MA, Monzingo AF, Ernst S, et al. The crystal structure of the antifungal protein zeamatin, a member of the thaumatin-like, PR-5 protein family. Nat Struct Biol 1996; 3:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/74\">",
"      Anzlovar S, Dalla Serra M, Dermastia M, Menestrina G. Membrane permeabilizing activity of pathogenesis-related protein linusitin. Mol Plant Microbe Interact 1998; 11:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/75\">",
"      Radauer C, Lackner P, Breiteneder H. The Bet v 1 fold: an ancient, versatile scaffold for binding of large, hydrophobic ligands. BMC Evol Biol 2008; 8:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/76\">",
"      Kleine-Tebbe J, Vogel L, Crowell DN, et al. Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1- related PR-10 protein in soybean, SAM22. J Allergy Clin Immunol 2002; 110:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/77\">",
"      Berkner H, Neudecker P, Mittag D, et al. Cross-reactivity of pollen and food allergens: soybean Gly m 4 is a member of the Bet v 1 superfamily and closely resembles yellow lupine proteins. Biosci Rep 2009; 29:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/78\">",
"      Mogensen JE, Ferreras M, Wimmer R, et al. The major allergen from birch tree pollen, Bet v 1, binds and permeabilizes membranes. Biochemistry 2007; 46:3356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/79\">",
"      Douliez JP, J&eacute;gou S, Pato C, et al. Binding of two mono-acylated lipid monomers by the barley lipid transfer protein, LTP1, as viewed by fluorescence, isothermal titration calorimetry and molecular modelling. Eur J Biochem 2001; 268:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/80\">",
"      Douliez JP, Michon T, Marion D. Steady-state tyrosine fluorescence to study the lipid-binding properties of a wheat non-specific lipid-transfer protein (nsLTP1). Biochim Biophys Acta 2000; 1467:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/81\">",
"      Tassin-Moindrot S, Caille A, Douliez JP, et al. The wide binding properties of a wheat nonspecific lipid transfer protein. Solution structure of a complex with prostaglandin B2. Eur J Biochem 2000; 267:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/82\">",
"      Pato C, Le Borgne M, Le Baut G, et al. Potential application of plant lipid transfer proteins for drug delivery. Biochem Pharmacol 2001; 62:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/83\">",
"      Sy D, Le Gravier Y, Goodfellow J, Vovelle F. Protein stability and plasticity of the hydrophobic cavity in wheat ns-LTP. J Biomol Struct Dyn 2003; 21:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/84\">",
"      Vassilopoulou E, Rigby N, Moreno FJ, et al. Effect of in vitro gastric and duodenal digestion on the allergenicity of grape lipid transfer protein. J Allergy Clin Immunol 2006; 118:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/85\">",
"      Ikura M. Calcium binding and conformational response in EF-hand proteins. Trends Biochem Sci 1996; 21:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/86\">",
"      Declercq JP, Tinant B, Parello J, Rambaud J. Ionic interactions with parvalbumins. Crystal structure determination of pike 4.10 parvalbumin in four different ionic environments. J Mol Biol 1991; 220:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/87\">",
"      Bugajska-Schretter A, Elfman L, Fuchs T, et al. Parvalbumin, a cross-reactive fish allergen, contains IgE-binding epitopes sensitive to periodate treatment and Ca2+ depletion. J Allergy Clin Immunol 1998; 101:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/88\">",
"      Bugajska-Schretter A, Grote M, Vangelista L, et al. Purification, biochemical, and immunological characterisation of a major food allergen: different immunoglobulin E recognition of the apo- and calcium-bound forms of carp parvalbumin. Gut 2000; 46:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/89\">",
"      Hilger C, Thill L, Grigioni F, et al. IgE antibodies of fish allergic patients cross-react with frog parvalbumin. Allergy 2004; 59:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/90\">",
"      Elsayed S, Aas K. Characterization of a major allergen (cod). Observations on effect of denaturation on the allergenic activity. J Allergy 1971; 47:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/91\">",
"      Bernhisel-Broadbent J, Scanlon SM, Sampson HA. Fish hypersensitivity. I. In vitro and oral challenge results in fish-allergic patients. J Allergy Clin Immunol 1992; 89:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/92\">",
"      Pervaiz S, Brew K. Homology of beta-lactoglobulin, serum retinol-binding protein, and protein HC. Science 1985; 228:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/93\">",
"      O'Neill TE, Kinsella JE. Binding of alkanone flavours to beta-lactoglobulin: Effects of conformational and chemical modification. J Agric Food Chem 1987; 35:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/94\">",
"      Takagi K, Teshima R, Okunuki H, Sawada J. Comparative study of in vitro digestibility of food proteins and effect of preheating on the digestion. Biol Pharm Bull 2003; 26:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/95\">",
"      Taheri-Kafrani A, Gaudin JC, Rabesona H, et al. Effects of heating and glycation of beta-lactoglobulin on its recognition by IgE of sera from cow milk allergy patients. J Agric Food Chem 2009; 57:4974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/96\">",
"      Chirino AJ, Ary ML, Marshall SA. Minimizing the immunogenicity of protein therapeutics. Drug Discov Today 2004; 9:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/97\">",
"      Wolf WJ, Nelsen TC. Partial purification and characterization of the 15S globulin of soybeans, a dimer of glycinin. J Agric Food Chem 1996; 44:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/98\">",
"      Yamauchi F, Yamagishi T, Iwabuchi S. Molecular understanding of heat-induced phenomena of soybean protein. Food Rev Internat 1991; 7:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/99\">",
"      Mills EN, Huang L, Noel TR, et al. Formation of thermally induced aggregates of the soya globulin beta-conglycinin. Biochim Biophys Acta 2001; 1547:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/100\">",
"      Mills EN, Marigheto NA, Wellner N, et al. Thermally induced structural changes in glycinin, the 11S globulin of soya bean (Glycine max)--an in situ spectroscopic study. Biochim Biophys Acta 2003; 1648:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/101\">",
"      Maleki SJ, Chung SY, Champagne ET, Raufman JP. The effects of roasting on the allergenic properties of peanut proteins. J Allergy Clin Immunol 2000; 106:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/102\">",
"      Chung SY, Butts CL, Maleki SJ, Champagne ET. Linking peanut allergenicity to the processes of maturation, curing, and roasting. J Agric Food Chem 2003; 51:4273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/103\">",
"      Gekko K, Timasheff SN. Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures. Biochemistry 1981; 20:4667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/104\">",
"      Koppelman SJ, Bruijnzeel-Koomen CA, Hessing M, de Jongh HH. Heat-induced conformational changes of Ara h 1, a major peanut allergen, do not affect its allergenic properties. J Biol Chem 1999; 274:4770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/105\">",
"      Gruber P, Becker WM, Hofmann T. Influence of the maillard reaction on the allergenicity of rAra h 2, a recombinant major allergen from peanut (Arachis hypogaea), its major epitopes, and peanut agglutinin. J Agric Food Chem 2005; 53:2289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/106\">",
"      Ilchmann A, Burgdorf S, Scheurer S, et al. Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II. J Allergy Clin Immunol 2010; 125:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/107\">",
"      MacLeod AR. Genetic origin of diversity of human cytoskeletal tropomyosins. Bioessays 1987; 6:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/108\">",
"      Brown JH, Kim KH, Jun G, et al. Deciphering the design of the tropomyosin molecule. Proc Natl Acad Sci U S A 2001; 98:8496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/109\">",
"      Naqpal S, Rajappa L, Metcalfe DD, Rao PV. Isolation and characterization of heat-stable allergens from shrimp (Penaeus indicus). J Allergy Clin Immunol 1989; 83:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/56/23433/abstract/110\">",
"      Brett GM, Mills ENC, Goodfellow BJ, et al. Epitope mapping studies of broad specificity monoclonal antibodies to cereal prolamins. J Cereal Sci 1999; 29:117.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2387 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-5450C57513-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23433=[""].join("\n");
var outline_f22_56_23433=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PROTEIN STABILITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Disulfide bonds",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Prolamin superfamily",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Thaumatin-like proteins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Chitinases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Other allergens with disulfide bonds",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Glycosylation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Rheomorphic proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      INTERACTION WITH MEMBRANES AND OTHER LIPID STRUCTURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      2S albumins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Alpha-lactalbumin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Non-specific lipid transfer proteins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Thaumatin-like proteins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PR-10 proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      LIGAND BINDING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Non-specific lipid transfer proteins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Parvalbumins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Beta-lactoglobulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      AGGREGATES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      GLYCATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      REPETITIVE STRUCTURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2042?source=related_link\">",
"      Food allergens: Overview of clinical features and cross-reactivity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/42/43689?source=related_link\">",
"      Pathogenesis of food allergy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_56_23434="Light microscopy teratoma";
var content_f22_56_23434=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F63138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F63138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 571px\">",
"   <div class=\"ttl\">",
"    Teratoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 551px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This mixed germ cell tumor contained teratoma and yolk sac tumor. Panel A: squamous epithelium, skin adenexal tissue (adjacent to squamous epithelium), and enteric-type epithelium are present. Panel B: cartilage (top) and yolk sac tumor (bottom) are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael Weinstein, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23434=[""].join("\n");
var outline_f22_56_23434=null;
var title_f22_56_23435="Criteria for phlebotomy in HH";
var content_f22_56_23435=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F60083&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F60083&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria for initiating therapeutic phlebotomy in homozygotes or heterozygotes for homochromatosis gene or genes and other persons with a hemochromatosis phenotype, regardless of genotype* (after exclusion of other causes of an elevated serum ferritin)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Patient",
"       </td>",
"       <td class=\"subtitle1\">",
"        Serum ferritin, ng/mL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Persons &lt;18 years of age",
"       </td>",
"       <td>",
"        &ge;200",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Reproductive years, not pregnant",
"       </td>",
"       <td>",
"        &ge;200",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Reproductive years, pregnant&bull;",
"       </td>",
"       <td>",
"        &ge;500",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Postreproductive years",
"       </td>",
"       <td>",
"        &ge;200",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Men",
"       </td>",
"       <td>",
"        &ge;300",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     *All persons with porphyria cutanea tarda should undergo iron depletion therapy to reduce the serum ferritin level to 10 to 20 &micro;g/L.",
"     <br>",
"      &bull; Unless substantial cardiac or hepatic dysfunction attributable to iron overload Is present, induction of therapeutic phlebotomy should be deferred until the end of pregnancy (a normal-term pregnancy removes approximately 1 g of iron from the mother).",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Barton, JC, et al. Ann Intern Med 1998; 129:932.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23435=[""].join("\n");
var outline_f22_56_23435=null;
var title_f22_56_23436="GA and BW characteristics of US singleton twin triplet births";
var content_f22_56_23436=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Gestational age and birthweight characteristics of United States singleton, twin, and triplet live births",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Singletons",
"        <br/>",
"        (1995)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Twins",
"        <br/>",
"        (1991-1995)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Triplets",
"        <br/>",
"        (1991-1995)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         No. of births",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        3,603,971",
"       </td>",
"       <td class=\"centered\">",
"        463,856",
"       </td>",
"       <td class=\"centered\">",
"        18,843",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Mean gestational age (wk)",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        39.03",
"       </td>",
"       <td class=\"centered\">",
"        35.77",
"       </td>",
"       <td class=\"centered\">",
"        32.48",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Percent very preterm (&lt;33 wk)",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        1.70",
"       </td>",
"       <td class=\"centered\">",
"        13.94",
"       </td>",
"       <td class=\"centered\">",
"        41.25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Percent preterm (&lt;37 wk)",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        9.43",
"       </td>",
"       <td class=\"centered\">",
"        50.74",
"       </td>",
"       <td class=\"centered\">",
"        91.03",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Birthweight (g)",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        3357",
"       </td>",
"       <td class=\"centered\">",
"        2389",
"       </td>",
"       <td class=\"centered\">",
"        1735",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Percent very low birthweight (&lt;1500 g)",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        1.10",
"       </td>",
"       <td class=\"centered\">",
"        10.12",
"       </td>",
"       <td class=\"centered\">",
"        31.88",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Percent low birthweight (&lt;2500 g)",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        6.06",
"       </td>",
"       <td class=\"centered\">",
"        52.24",
"       </td>",
"       <td class=\"centered\">",
"        91.52",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Percent small for gestational age",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        9.38",
"       </td>",
"       <td class=\"centered\">",
"        35.63",
"       </td>",
"       <td class=\"centered\">",
"        36.57",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Oleszczuk JJ, Oleszczuk AK, Keith LG. Twin and triplet birth: facts, figures, and costs. Female patient. 2003; 28:11. Copyright &copy; 2003 Jaroslaw J Oleszczuk, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23436=[""].join("\n");
var outline_f22_56_23436=null;
var title_f22_56_23437="B19 associated conditions";
var content_f22_56_23437=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F62492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F62492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Conditions associated with parvovirus B19 infection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Cardiovascular",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute heart failure",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Myocarditis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pericardial effusions",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pericarditis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Cutaneous",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            <strong>",
"             <em>",
"              Gianotti-Crosti syndrome (papular acrodermatitis of childhood and papulovesicular acrolated syndrome)",
"             </em>",
"            </strong>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            <strong>",
"             <em>",
"              Papular-purpuric gloves and socks syndrome",
"             </em>",
"            </strong>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            <strong>",
"             <em>",
"              Vascular purpura",
"             </em>",
"            </strong>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute renal failure",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Erythema nodosum",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Erythema multiforme",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Livedo reticularis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Hematologic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            <strong>",
"             <em>",
"              Hemophagocytic syndrome",
"             </em>",
"            </strong>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Aplastic anemia (not transient)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Autoimmune hemolytic anemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic neutropenia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Thrombocytopenia purpura",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Transient erythroblastopenia of childhood",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Juvenile idiopathic arthritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Hepatobiliary",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Elevated liver enzymes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute liver failure",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Neurologic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            <strong>",
"             <em>",
"              Brachial plexus abnormalities",
"             </em>",
"            </strong>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sensorineural abnormalities",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Meningitis/encephalopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Seizures",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Ocular",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Conjunctivitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ophthalmoplegia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Renal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute renal failure",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Nephrotic syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Respiratory",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acute chest syndrome in sickle cell disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pleural effusions",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pneumonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Rheumatic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Autoimmunity and immune mediated inflammation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Juvenile idiopathic arthritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Rheumatoid arthritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Systemic lupus erythematosus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Vasculitis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Those for which B19 is more likely to have a causal link appear in bold.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Torok TJ. Unusual clinical manifestations reported in patients with parvovirus B19 infection. In: Monographys in Virology: Human Parvovirus B19, Anderson LJ, Young NS (Eds), Karger 1997; p.61.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23437=[""].join("\n");
var outline_f22_56_23437=null;
var title_f22_56_23438="Gram stain sputum 10A answer";
var content_f22_56_23438=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F70618&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F70618&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nocardia in sputum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 365px; height: 234px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gram stain of sputum (x1000) shows inflammatory cells and thin faintly-staining, beaded, Gram positive and branching filaments. This gram stain is consistent with either Nocardia or Actinomyces. Nocardia grew aerobically from this specimen on Sabouraud's agar. Nocardia can also be differentiated from Actinomyces with the acid-fast stain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23438=[""].join("\n");
var outline_f22_56_23438=null;
var title_f22_56_23439="Nebulizer iNeb";
var content_f22_56_23439=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F79862&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F79862&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 483px\">",
"   <div class=\"ttl\">",
"    iNeb nebulizer showing device and principle of operation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 463px; height: 269px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAENAc8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKK8z+MniPU9DTT00q48gy7mc4yTivBl+OPjWG7eEXFtKA2BmLmt4YdzSaZnKok7H2LRXyvafG/xdHg3UVqw9NmK6TTPj3LwuoWWPUoKt4SfdE+3ifQlFeUaF8Z9I1G+gtpIZUMrBAw7E+terKQVBHQjNY1KUqfxI0jNS2FooorMoKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPFP2g5dt1pg/6ZyGvl2x+bW+e719L/tEHOoWI/uwOa+ZLGZY9U81ugbNenQ+CJyVPiZ6GqBmwwU/UVJLaQkDdCn5Vo+BrLV9fmaTSdPSWGP7zy/drs5za2z/Y/EehmNj/AMtYDgitXe9kSrWuzhfDdpCviHTikYVvtKDj619fx/cX6V8yW+lW9l4w0f7FcCe2muVKZ4ZfYivptfuj6Vx4t35TaitxaKKK4zcKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKhvJ1trWWZzhUUsaAPCP2g383WIIo/mdbduB718+Q6BcwL9pvE8uLPTua9e1vVn13X7+9mO5AxSMHnAHeuH8ZX4WNYl9c169KHKkmcc5XbaOl8L/EK40S1jtNNiSG3XsByT6mtW68T3PiG/jaQgtXiyXJ3dTXdfDa4V9dgErfKTzmupKC95bmEnJ6XPffDej6b4gsrG9WFYdS0+UEsP4h716kOgrzmBU8O+I7OWM4tL9QremfWvRV6CvHxOsr9Gd1LRW6i0UUVzGoUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFACHAGTwKytU8RaTpak319DFjsWyfypvi2eK28O3008jRokZJZTg18k6jeTanqTyNI5DNxk9BXXhsMq123ojCtW9noj6Sufip4YhYhbtpT/sITXPeKPiPba5pzad4fRjcz/KWm/dqB9TXl2n26Qxg7QTjqRXOfEa4I0yGJGK75B904rrWHoxeiZj7Wb6nR2Gh39tJLHP5Kq7ct5gOKmvPh7pWroxuNae2uD907Mrn3qnospjsbdc9EHWt23vGX+KtpyT6EQTXU8U8R6JdeH9Se1uSJEB+SVR8rj1FaXgu7MGqwNno1dP8AFtHudLtbgc+U+D7ZrgdDlMd1G3oaIu4NH1J4s1RZ/DWmXCN+8hZTmvUdD1CK+0u1mEiFnjBIzz0r5muNaM3hxYiT8uK7bwbJb3WgQS3SzeduIEkcpUgVzVaKcFfuawqPm0PdRz0orzGC5ngYfZNYu41/uzAOK6Tw9rlxJfLZag8MrSLmKWMYzjsRXFKjyq6dzoU77o6qiiisSwooooAKKKKACiiigAooooAKKKKACiiigAoqO4jaW3ljSRondSokTGUJHUZ4yK+e11HxLY3PxOe/8W6zf2vhWEeTAfJhNxvt2bLOkYZSDggqR0HWgD6Ior55+I/xH16TQdbstFmt9Nj0mDSWmuHnf7ZO9w0TfusY+UKSrE5z81dL/wALXv8A/hZtvocNtY3ejTarJpDTxB0kimRSSCWOGII5wuPRjQB7DRXlfwx8Qa5N+z7Ya8GbVtcSxnuB9qckzsjvhS3XJC4H4Vk2/wAZbzVdH/tPRdOs/sN5qdjpFjdXMjBFmmhEkrS4/hjJCcdW70Ae1UV4Q3xG1fUte8IT8QGC91uzvIbWVjbXrWtsxV17shYAjOcGtC3+Mslzpdrc2trp80r+FrnXpo4593lTRAERHHQE5HPPFAHs9FeB3Hxh8W2dtfXd3o2hG3sodOv5hFczFzb3bKqouVxvBbJJwB6GtzT/AIp6zqHxCuNJttFgbR7bV20idy5EyEcCYkkLtLYwmMkEEE0AewUVwviO9vL34peGtAhvJ7SxjtLjVrgROUN0Y2jjSIkc7QZCxHfAzXnGg+MNbN5pVuLu4uby61jX4YXnuXEaiCJ2iV1GdyggAA9OooA+gaK8M8G/Efxhd+GvAcTQ6LqmteIzdKJpZ2hRRFD5gMmxDtb72Qq4xt6ZJFrSfi1rl/4surVdCtTpNtf3GnTN53lyRPEDh2dyFAZh93GQCDk0Ae00V414L8a6t8Q7fXdD1R49A1IWH2iEW3nRT2+SQsgkPySICB8ykA9MYzXb+A9cvvE/ww0nWHlitNSvdOEhmkj3Rxy7cbymRldw3YyOOMjrQB11FeXfBfxfPfeAL3U/F+uWskttqU9vJdzskCKol2IOwUEkAZPcDJrN8QazexfGnR9O0DxZc3ErT79V02ZohaWttsAVB8obzmblRuLc5IA6gHsdFeEfDz4kaz4g+Odzp2oyXtro13pUs1lpk1hJE0DrMFVpCyA5ZEZt2dmXCAlhivd6ACiiigAooooAKKKKACiiigAooooAKKKKAPNPjzqjWPg1reM4e6cJ+HU1876Sm65B9K9Y/aPvT9v020DcBC5HvmvL9ATMhY17OEjy0b9zz67vUsdFHlYgD1rifiE265sIvVs12rNiuC8bP5mv2CdhzT6gjqbN8RIuegFaMMvTmsW3kAAq7FNkU2hJkviSEX+g3cJGTsyv1FeT6UCJgD1HBr1xHDKVPQjBrza6tPsWuTxY+XduH0NEVqNs6pyRpCgdcivT9AAtNItISeQgJ+prziwg+0R2sWMguCfpXfrKM/L0HFKq7pIdPds3UuPQ1f0bUFg1vTpH6ebt/MVzK3HvSS3Rj8uTPMciN+orlcb6GyZ9CUVHbSia3ikHR1DfmKkrzzpCiiigAooooAgsrqK9tIrm2bdDKu5TjGRU9Y/hD/kWdO/65CtigAooooAKKKKACiiigArOfQtJf+0d+l2Df2iAL3Nuh+1ADA83j5+OPmzxWjRQBiah4S8OalNFNqPh/SLuWKNYo3nso5GRFOVUErwAeQO1PPhbw+dXOqnQtKOqGQSm8+xx+dvAwG343ZA4zmtiigCtpthZ6XYxWWmWlvZ2cQIjgt4xHGgznhVAA5JNU08OaHHo0mkR6Npq6TISXsltUEDEnJJjxtPPPStWg0AZ0GhaRbiwEGlWEQ08OLPZbov2bcMN5eB8mQSDjGQap23g/wAM2vnfZfDujQ+dHJDL5djEvmRv99GwvKtjkHg963aKAMmXwzoUsUsUui6Y8cscUUitaRkOkRzGpGOQhAKg8Dtiifw5oc2sJq82i6bLqqEbL1rWNp1xwMORuGPrWtRQBh634btNX1nRtVea5ttQ0qV3hmt2UF0cYeJwwIKNgZHByoIIIq1BoGj288E9vpOnxTQSyTxSJbIrRySDEjqQMhmB+Yjk960qKAMjT/DGgadJBJp+h6XavBK80TQWkcZjkdQrupA4ZlABI5IGDRN4Y0GbVv7Um0TS5NTxj7Y9pGZsYxjfjd0461r0UAc1ceCtFXQtT0rRrSHQYtRQx3E2kwRW8jA8HnYRnBIyRkZ4wea1rbR9Pt9Dj0aOzgOlR24tBaugaMwhduwg8EbeCD1q/RQBg2ngzwvZWd1aWfhvRbe0uihuIYrGJEmKHcm9QuG2nkZ6HkUsvg7wzLq41WXw7oz6oJROLxrGIzeYCCH37d24EDBznit2igCr/Ztj/av9p/Yrb+0vJ+zfa/KXzvK3bvL34zt3c7c4zzVqiigAooooAKKKKACiiigAooooAKKKKACiimudqMewGaAPl346X4u/HVwinKwIqD69657QF2w7qh8dXZvfFuqTk53TsB9M1b0dcWyfSvfjHlpJHmN802zQdia4HxI3meLIF67QK70jtXn+snd4z9lArJbl9DoQcDg4qWGRgME5qoGyMgZp6txg1rYi5qxSe9YniS133EV2g5HytV+OSpjtkXa4yD61GzuUWdA+WJX9BgVvRTn1rDtiI0CoMD0q5HLx1qJalRZrCb3qO6l/0eTnoM1REx9aZLN+6cf7JrOxVz6Y8MS+f4d02TP3rdD+lalc/wCAZPN8H6U3/TECugrzJ6SZ2LYKKKKkYUUUUAYnhiaODwrYSTMERYhkn61sRSpLGskTB0YZDKcgiub0LD6L4djIyCSxB9Aj/wBcVqWyfYtTeBeILgGVF7KwxuH45B/OqtoK5p0UUVIwooooARmCqWYgKBkknAFZ1nqJubzasRW1dMxStwZCDzgdhina0PMto4D9yeVI2H+yTz/Kk1T9zLZ3WPkhlCtjjCt8ufoMg/hVJIRo0UUVIwooooAKaSoKqSAT0GetOrnTG82m/wBsEu9xlbmMY5WIHOxR6lMj3JqkribOiopEdZEV0YMrDII7ilqRhRRRQAVWvbuOziV5Q7FjhVRdzMevA+gNWaz4x5+syOeltGEX/ebk/jgD86a8wZdhlSeJJYmDIwyCKfVDScILqEcCOdgB6A8/1q/Q1ZggooopAFFFIxCqSegGaAKA1OM6gLYIxQsYvNB+XzMFtn1wD/KtCsWK0efwxEkYAumiWdWP/Pbhwx/4Fya1bWZbm2hnTO2VA4+hGaqSS2EiWiiipGFFFFACEgYyQMnApaxLy3bUbi9PX7OoW3weFlxnP1BwK1LGcXNpDMDneoJ+veqashXJ6KKKkYUUUUAFVtSlEGn3MrdEjY/pVmsDx3ObfwlqcgOD5LAU4q7SE3ZXPj++k+0alcSk/flZv1rotM4gX6VWsfD9zcSbim0Zzlq6K38OzRxDM6A+le7UqwStc8yEJPWxns2AK891I7vF059B/SvVptDdVz9oUmuFuvDV0viC4uBJHIrDgA81hGpFvc1cWlqQRysBxUokycnrTZrKeEkOhGKiUMvWunQysXkerUb8isxXIq5byAj3pNDTNGN6sK/FUkkX6VIH9DWbRRb83imPIdpHtUBfj3prMSKloaZ9M/C6TzPA2lt/sEfqa6quJ+DsnmeAdP5zgsP1NdtXk1PjZ3Q+FBVfULn7FYXN0YZpxBE0vlQrukfaCdqjuxxgD1qxRUFHng1z4jvH9vTwho62fUae+qkXpX6iPyg3tu9s967nSrv+0NLs70289qbiFJvIuF2yxblB2uOzDOCPUV4pFpmq/wDC1b241jTPHV4p1pHs7u2vfLsIrfMe0NHvGUU7t3ByPckV7rQBzPhb5rPRQei2bsPruUf1rX1T5GtJv+ecwyfZgV/qKzPCaZs9PI/5Z2MYP1bn+lausoX0yfb1UBx/wEg/0quqEXaKbG4eNXHRgCKdUjCiiigCjf8AzXVin/TUt+Smp763F1ZXFuTgSxsmfTIxVe651exHosjfoB/Wr9VtYRX064+1WFtcEYMsauR6ZGasVn6Qdi3FseDDMwA9FY7l/Q1oUpKzBBRRRSGVtTlMOm3co4KROwP0BNPtIhDaQxAcIir+Qqtr3OiagO5gdR9SpFX6fQRnaJ+6t5LUDAtpDGoPXb/D+laNZ8Y8nW5B2uIQ/wCKHH8m/StCiW9wQUUUUhhVDSRzesepuX/TAq/VHSvuXP8A18SfzprZiI7kG11OGdT+6uCIpR/tfwn+laVUNaGLISnpDIkv5MDV+h7IAooopDCqurSeVpV5J/dhdvyU1aqjrfzaXcJ3kHl/99HH9acd0Jlq3j8mCKMdEUL+QqnoeF09IR/y7s0Gf904rQrP07Ed7fwL90SCUf8AAhk/qDTWqYGhRRRUjCiikdtiMx6AZoAoaGN2nrP3uGaY+245pNMP2e4ubM8BT5sY7bG7D6HP51Loy7NJs19Il/lTLr5dUsW6bg6H8gf6Vb1bQi/RRRUDCiiigArkfijfrp3hK4ldN4JC7fWuurzX48SlPCMaA/fnWtaMeaokyKjtFs8Nvtbu7uXhhEn91KbDNKRzK5/4EazY/v1eir2nCMVZI85Nt6kzSybTmV/zNcxo+pXSareNHN5iq2NknT8DXRyfcJrjNH5ur1vWQ1nypuzNLnbQaxDIB9st2j/2l5FWBDpd59yaLJ9eDXNK7KeDUqlTgsgJ9uKTopaxdg9pfc6L/hG4pBmJ/pgg0L4XuBzGwP1FY0bY+5JJH9Gq7DdXicR38o9iajlqraQ7w7Gh/wAI5ef3VIqaPw3dnqB+VVI7/VAMLfHFP/tDUm4N+34UWq90P3DRTwzKAC8oWnppWmWrbr64VgP4S1Yk01zIp33FzLgZIWsf+0rWRwFjlYju3NS4TfxSHzR6I+qPhvJaS+E7VtPULb5IAAwOtdRXHfCezNn4Jscyb/NBkHoM9q7GvNqK02kdcNYoKgvrSC/sbizu4xLbXEbRSoSQGRhgjj1BNT1De3UNjZ3F3dyCK2gjaWWRuiqoySfoBUFHzmtjoL/GJlXw94OsLqx1mCBHv9bkjv5CpjKSxQ5wxIK7R3Iwe9fSVeNeHvBT3/i248T+G9c8LX+i3mqDUWxpkdzMOULqtxuJVvlJB/hJ6dq9loA57wV+80lZs/LgQL6ER5XP44Nb0yiWJ4z0ZSp/Gvj7U/iV4z0fxDquk6droisbHUZ7SGM2ynbGsmAM/SvoP4Ea7qXiX4ZaZqmt3X2q+maXdLsC5AcgcD2FdtfBTo01VbVnb8jCFeM5OC3R2mjyGTTIN3VV2H8Dj+lXaoaThRcxD/lnMw/Pn+tX645bmy2Ciig0hlEqX1hGAyscJBPoSf8A61Xq+bP2qNVvLXxR4ctrK+urX/RJ5X8iQpu5AGfXpW/+ypeXd7oniQ3t5c3TJqAVTPIXKjYDx+dd0sFJYdYi/wAvmYKsnU9meyR4i1yVR/y3hEh+qnb/AFFaFZ9x8ms2b/30eP8Ak39K0K4n0NkFFFFIZna9IkWmO0zrHF5kYd3IAVS6gkk9sVYtL60vC4s7qCcx43+VIH256Zx0rgf2iJjB8G/EbLwXSGPr/enjX+ted/sjKq3HjIKCAGsh1J/5ZyV2Qw3NhpV77P8Ay/zMXVtUUO577ffLeae/8RlKH6FGP8wKvVR1M4ksT6XA/VWH9avVyPZGoUUUUhhVDSQQLvdxm5kx+dX6+UIb6W7/AGrlInn8pdVeHyxIdvyQMOnTqK6sNh3XU9bWVzOpU5LeZ9TajCbiwuYR1eNlH5U+ym+0WcE3/PSNX/MZqaqOi8abCn/PLMX/AHycf0rm6F9S9RRRSGFZPie9tdP0sXd/cxWtrFPC0k0zbVUeYvU+5wPxrWryj9pyUJ8JL2Fulzd2sRHr++Vv/Za1oQ9pVjDuyZy5Ytno+ja1pmtwSTaPf217FG/lu8EgcK2M4JHsRQQY9cQjhZbc7vcqwx+jGvHf2S0VfBeubFC/8TV+g/6ZpXsl/wDLf6a47ysh+hjY/wA1FXXpKjVlTT2Jpz54KReooornNAqG9DNZziMFnMbBR6nFTVT1e5+x6TfXQ4MEDyf98qT/AEprcDL8OeJtC1Yx2OlavZXlykO8xwShmCghScfUj860dT4msG7+eF/MGvlf9lJEHxRuyqqCdFlbgf8ATxHX1Rqpx9jP/Tyn9a68Xh1h63Incxo1PaQ5i/RRRXGbBRRRQAV5P+0HLjQrGL+9Nn8q9Yrxj9oibEekxZ6szV0YVXqoyrfAzxVPvVdiORVJDzVuLpXsyPPjuPkbCMM9jXG6Kfnuz6ymuslb98y/7BNcpon3rsHtIazW5b2NhOcd61o9C1VoPPXT5zFjOdtXPh/p8d/r8QmAMcQ3kHvivZbaVZpZY0YbolBK+3tXNiMS6UuVI1pUuZXZ4Ev9cVZTCruJwB3NbfxB0+HTfFCtbALHeRmQoOgYdSPrXIeJrhrfTDt6tXRTqKcOcymnF8p6H8M/DyeK7ye4kdxptqdrbf8Alq/pn0FeqRfDzRD1tm/M1W+CWmR2Hw40gIoDTqZnPqSa9EjTAry6taUpN3O2FOKic1pXhLSdKYva2aeYeCzjdx+NeSfGTwZHpL/23pcax2sp2zxKMBG9R7V9BleK5jx/YJqPhPVLeRcgwsw9iOaVGtKM02xzgnGxZ+Guf+EH0jPXyRXTVznw7Up4K0gHr5C10dZ1PjZUPhQVBfXBtLG4uRDNcGGNpPJhXdJJgZ2qOMsegHrU9QahaR39hc2kxcRXETROUYqwDAg4I6HnrUFHh8q6HrniC3l074f+P/C+rXUqRHVrCzSzEe5sb5dshVlGcksrcA17nbRtFbxRyStM6IFaRgAXIHU44ya4AeDPGKR/Yk+It5/Zn3QzabC14E9PPzjdj+Ix5713OlWUemaZZ2EDyvFawpAjTOXdlVQAWY8k8cnvQB8NeKVY+PPEhCsR/bV12/6amvpv9mTK/BrRMgj5puv/AF0ajTvhH4L1y0XVtR0jzb6+Y3NxIZnG6Rjlj14ycnFdp4X8J6b4X0SDSdD8+2sYWZ0j80tgscnk89a9TFY6FahGlFO6t+COSjQlCo5t7mjY/Lf6gn+2rfmv/wBar9Z1qvlarNHuZswq2WOSeSK0a8yR1IKKKD0pDPlH9qKY3HxOsYlViLfSgDgd2kY/yxXafslgroXifcCP+JiOo/6Ziu61z4beFvGGtXmqa9pxub0N9n3+ay/IoGAAD71q+EPAeieD7a8g8OxTWkV3IssoErNlgMcE9K9SrjYPCqgk76HJChJVXUvobd/xqWmH1kcf+Q2P9K0Ky7i3MV9pzmWV/wB8ww7ZH+retSvMeyOpBRRRSGeU/tNTbPhTcxD/AJeLy1i/8jK3/stcZ+yOCLjxnkEfNZdR/wBM3r1/x54Y0rxhBp+k67A89n55uNiyFPmVTtJI5/iNR+EPh7oHg43v/COQS2RvNnn7ZWbdszt6njqfzrvjiYRwkqFtXr5br/I53SbrKp0R0GrcQwuP4J4z+bAf1q9WRqtsYrQObiZgssRwzcH94ta9cPQ3CiiikMCcDJ4Ar4w+HV0+pfHvStQZW/0vWLmbkdij19g64A2kXiNuAkjMfynB+b5eD+NcJ4e+C/g7w/q9lqmmWdxHfWb+ZFIbh2w2COQTg9a7sJiIUITUt5KyMK1OU5Rt0PSao6R/x7yj0nlH/j5p32Js5+1XH031Foq+XHcxlmYrcPyxyTk5/rXEtmbGjRRRSGFeI/tX3JTwPo1sp/4+NWiyPZVdv6V7dXDfELwPpnj28sbLWZLpYLENOggkKZdvl5/Dp+NdGFqRp1ozlsjOrFyg0jiP2Tf+RL1zP/QVk/8ARaV7DqvAtH/uXMf6nb/7NXO+BvAOneCdNuLHQ7i7SCef7RJ5km8ltoXqe2APyFbWoW0kUMTtdSyAXMPynGD+8Uf1p4iqqtdzjsxUoOEFF9DXooormNQrn/iHMbfwB4mmHWPTLlx+ETGugrE8YafFrHh+50m5aRYNQxaSbGw2xzhwD/u7qum7TTYpbHzN+yqpX4n3AIP/ACA5P/SiOvqbVv8AUwN/dnjP61xXgr4S+HvBusPqehtex3b27WpZ5y42EhiMH3UGur1O1eGzMn2qdtjKcM2QfmHBrqxuIjiK3PDYyo03Thys2KKKK4jYKKKKACvB/wBoWXdrGmxf3Yya94r54+PsobxfAmfuW4/ma68Ev3qMMR8B5ogyauR9KqQ/eFW4xxXrSOGO5Skl26ysRP34Sa5/Svlvb9P9vNX9Wn8nxTp3PDoymqEI8vxBep681lF6mjOv8HaoNJ1qKeT/AFTfK/0NewR3tiB9pS4hAI+/uA4968FXAqZZ3xt3tt9M1lXwyqvmvYuFXk0Oh8X6qmteIvOhH+j2y+VGx/jPc/Suc8SWrXejymIZeMZIHpUyNVmGcxuGXB9j0IraFNQhyIzlJylzHu/wJ1aLUvhtpe1gZLYGCQZ6EV6Sjg18zfDjxFF4S1qXZC40e+I89V+byJOzgelfQNpqEc0SSRuHRxlWHQivIrUnCTTO+nNSV0bZbiuc8dXqWPhXVJ5CABCVHuTxWqtwNuScAdSe1eL/ABb8Yxave23h/S5BLB5y/aJF6M2fuiihTc5pBUkoxuey+DojD4V0pCMEW6Z/Ktmq2mR+Tp1rHj7kSr+QqzWcndtlJWQUUUVIzwHWdb17R/jdaWS6zqWh6TfahGvl6nKbq31AMwHlWyLEfILc/ekHPOK9+r52XV7Ox+M9zNBpXhT7dNriWD2csUkmqsrbQbpXbIVQDvwAF2DrmvomgDI8If8AItad/wBchWvWR4Q/5FrTv+uQrXoAon5dbUn+OAgfg1XqoXfGrWB/veYv/juf6VbuJ47eCSadwkUalmY9AB3qn0EOdlRSzkKo6knAqk2rWgVirs6qDkohI+n1qC3t5NSYXN+jLAeYbZuw7M47t7dq1AigYCgD0AosluBU0lJFtN8y7ZZWMjKexPb8sVdooqW7jKOq/L9kcfw3Cfr8v9avVQ1ri1hPpcwf+jVFX803shdQzUNzdQ2ygzyKmemep/CqU93Lc3TWunkfIcTTkZWP/ZHq38qmtdPhhfzXzNcHgyyHJ/D0HtTtbcLkFvKLzVhNCCbeKIpvIIBckdPXgVqUgAAAA4paTdxlHWxnTZO/zIf/AB8Veqnq4zpd1/sxlvyGf6VZibdCjeqg0dBD6r3d3DahPOYhnOEUDLMfYVVvbuV7n7HYYM+AZJCMrCp/m3oPxqa0sI4JTMzNLcEbTLIcnHoPQU7W1YFW7ukvzDb2oaQmZHdtpARUYMc59duPxrWpoUDoAKdSb7AFULD5b/UVz0kU/moq/VCz/wCQpqP1j/8AQaFswZfpGYKMsQB71U1G9WzjQKpknlOyKIdXb+gHc9qhg07zP3uov58x7fwL7Af1ot1YE9xqFrAvzyqWPRE+Zj7ACo9MjlLT3U6+W87AhD1VQMDPv3/GrMNrBB/qYUT6CpqL9gCqWsf8ekf/AF8Qf+jUq7VLV/8Aj0j/AOviD/0alEd0D2LtFBrOnvZZblrbT0V3j/1sjfcT/Z929u1CVxl+SRI13SMqr6scVm3E8d1qVhFbusnlyNNJt5AXYyjn1ywqSPTVdxLeyNcyjpv4VfovSrscSR/6tFUHrgYp6IW4+qOu8aVcH0AP6ir1Udd/5BF1/uUo7obL1FFUYLt7m/kjhQfZocq8v95/7o+nOffilYC9RRRQAV8zfHCbzPHc4z9yJVr6Zr5Y+MD7/H2o89No/Su3AK9T5HPifhOWt+tWlOKp23WrQPFepI4o7nIeMpfJ1zTpAeVH9akuzt8QJIPuzRg1T8eZ+2259EpZpvMtdOuR1Q7DXPF+80ayXuo3h0p8fvUaHK59as2UYluIoz0ZgDW701M9wBHrT8+9dm/hmDoFxUX/AAi8WeMiuT6/S8zX2MjloLh4nDRuVb1FbVr4i1WJVWK/lQDoAeBUWsaXHYxFwM4Fco2rhZEUQcs4XO7pTWLpT0D2U1qd3c+JtYvLOS0uNRmEUgwSvB/OqWgaDcprOny+bbPEJ0YkSDOM+lZIlOSD2q/oBD67p69jcJ/MV0NJLQzu29T6+TGxcdMUtIowoHoKWvBPTCqmrmUaTem3na3mED7JlQOY22nDBTwcHnB4NW6ZLGs0TxyDcjqVYdMg9aAPDfhjJr/ivXoL9fHN7M9rbWV9cR3GgWUZmgn3MIRImWGRGwOMYyMZr3WvNdJ+Bvw60jVbPUtP8PeTe2cyXEEn225bZIjBlODIQcEDgjFelUAZHhD/AJFrTv8ArkK16yPCH/Itad/1yFa9AFDUvkuLGX+7Nt/76BFR3ifbNShtn5t4QJ3Xs7Z+UH2B+b6gVJrPy20ch+7HNG5+gYZpLQ79Wvz2TYg/LP8AWrW1xGhRRRUDCiiigChrfGnO/wDzyeOX/vl1b+lLq7SfZ0hgcxy3EgiDjqo6sR77Q2PfFLrSNJo1+i/eaCQD67TUc7ie+0zZyPmm/DYV/wDZ6tbITLdpbRWkCQW6BIkGABU1FFQMKKKKAIruLzrWaL++jL+YqtZ3AGkRXDdFiyfwH/1qvVg/8wRLTozTfZ/p83P6VUVdWEzR0iExWSO4/ey/vZD3LNyfy6fhV2iik3d3GFFFFIAqja8apfD1EZ/Sr1Z4OzXiuMCS3zn3Df8A16a6iYzTlFxfXd44yQ5gjz1VVOGx9SP0rTqhoXzaPZueskYkJ9S3J/nV+iW4IKKKKQwqjrJxZKfSeE/lKtXqp6wpbSrvaMuI2ZR/tAZH6inHdCY/UpzbWM0qcuq/KP8AaPA/UiiwthaWcUK4yo+Yju3c/iarXz/aI7CNTlZpVYj1UAt/MCtKh6KwBRRRSGFU9XUtpl0B/wA8zVyo7hPMt5U/vKR+lNOzAhuroW+mS3QXd5cJkC+uBnFLp1t9ksoYM7mRRvb+83dvxOTWfMwk8PWyE/61Yoj/AMCKqf51smm1ZWEFFFFSMK+TPirL5nj7ViOgkA/SvrJj8pNfH/jyXzvGWrPnOZyK78vXvv0ObE/Ciha9KsKOKhtx8n4VOo4r0ZHHHc4vxsN14n+5WdpzmbTJYe6fMPwrX8WpuvwP9iue02TyLwqejcVzbT9TfeJ1tlJ5ltGw7itTTCBfW+f+ei/zrB0ZvkeM/wADcfStyxO28gP+2P510PWJjsz2YxjgkdhUToFBwOanzlVP+yP5VE7DBzXzJ3nIeMsCzY+1eSsf9JgHrKP516t40b/Q2ryuJQ2o2oPQyZroor3kN/Czo2bEr/WtDw8+PEGme9zGP/HhWdIB5r896taGw/4SXSAP+flCfzFe9LZnnrdH2fRRRXgHqBRRRQAUUUUAZHhD/kWtO/65Ctesjwj/AMi1p3/XIVr0AQXtuLq0mgLFfMUruHVT2I+lJZWqWkIjQliSWZ26ux6k1YoovpYAooooAKKKKAEIBBBGQayNFtrhHia7Ta9tbrbKc/fPG5voSBitiimnZWFYKKKKQwooooAKy4LKYaizSFPsqOZo8H5i7Ag59hnitSimnYAooopAFFFFABWfqtlLd+SbebyWUsGcfeCspB2nsRkEH2rQopp2d0AyGJYYkjiULGihVA7AU+iikAUUUUAFBAIIIyD2oooAyNMtbhJ4hcABLSMxI2c+aTjLY7dMY9zWvRRTbuAUUUUgCiiigDCs4ZZpltmR0t7SdnLOMCQ5JQL7DIOfat2iim3cSQUUUUhjZTiNvoa+NfEjeb4j1F853Tv/ADNfY162y0nb0Qn9K+MdQbzNUum9ZnP/AI8a9HL1rJnJinoixbj5D9KmUUy3HyVLXdI5IHK+JV3amB/0zrlbxTFOrAd+a63xAP8AibD/AK51g6lBlMgVhUjpdG8H0LmmTYnjbs4wfrXRwHEsbf7QritNl42H7y8iutspfMiVs1tB8yMpqzPboXDQx/7o/lTJOnFYtn4jshawoZF3BAD+VOl8QWzD5Cpr590pp7HappmD45bbbEV5pAP+JlZ/7xNd94nvzeLtSFjn0rjhZXH9oQz+UViTqTW9CnLnWgSkuVmg5y7Y7mrGiceKNK9rmP8A9CFV1HJJ6DmptDP/ABUWmE9ftMf/AKEK9uWxxR3PtUdKKRfuj6UtfPnqBRRRQAUUUUAc7os17p2l21nJpdw7wLsLI6bWx3HPSrv9p3f/AECbr/vpP8a1aKAMr+07v/oE3X/fSf40f2nd/wDQJuv++k/xrVooAyv7Tu/+gTdf99J/jR/ad3/0Cbr/AL6T/GtWigDK/tO7/wCgTdf99J/jR/ad3/0Cbr/vpP8AGtWigDK/tO7/AOgTdf8AfSf40f2nd/8AQJuv++k/xrVooAyv7Tu/+gTdf99J/jR/ad3/ANAm6/76T/GtWigDK/tO7/6BN1/30n+NH9p3f/QJuv8AvpP8azfGvjvw74Jjhk8TXstnHKCVkW0mmUAEDlo0YLywHOM5qbQfF+la9Iv9m/bDbm3NwLie1kgj2hyhB8wKQ2QTgjpzQBc/tO7/AOgTdf8AfSf40f2nd/8AQJuv++k/xq2upWLMFW8tixk8kASrkyYzs6/ex2608Xlsbs2ouITdBdxh3jeB67euKAKP9p3f/QJuv++k/wAaP7Tu/wDoE3X/AH0n+NN1bxBZaZrGk6XN5sl/qbutvDEm47UGXdv7qKCMk9yAMk1fjvrSW5lto7qB7iLmSJZAXT6jqKAKX9p3f/QJuv8AvpP8aP7Tu/8AoE3X/fSf41bj1GyltHuo7y2e1TO6ZZVKLjrls4FB1GyCW7m8ttlwcQnzVxL/ALvPP4UAVP7Tu/8AoE3X/fSf40f2nd/9Am6/76T/ABq7Je2scyQyXMCTO2xUaQBmbGcAdzjtWVrXivSdH1XTNNvLkG91C5FrDFHhmDlSw3Dqowp5NAFj+07v/oE3X/fSf40f2nd/9Am6/wC+k/xqPWfEmnaXpeo3zy/ak09DLcxWhEssaj7xKA54GSe/FadldQX1nBd2cqTW08ayxSIcq6MMgj2IINAFD+07v/oE3X/fSf40f2nd/wDQJuv++k/xrVooAyv7Tu/+gTdf99J/jR/ad3/0Cbr/AL6T/GtWigDK/tO7/wCgTdf99J/jR/ad3/0Cbr/vpP8AGtWigDK/tO7/AOgTdf8AfSf40f2nd/8AQJuv++k/xrVooAyv7Tu/+gTdf99J/jR/ad3/ANAm6/76T/GtWigDK/tO7/6BN1/30n+NT2N5PcTMk1hPbqF3b3ZSCfTg1eooAKKKKAKOuv5ejXz/AN2Fj+lfG5G65kb1dj+tfY3iBY30S+WeQxRGFgzgZKjHJr491029jqZTSHkvrTGfNK7Tn0xXo4BpKRyYpbF+3A8hvWg9Kq2t6rRFXhmQn1WpWuI8fxflXW5I5lFnO69zq6j/AKZ1Tni3xfhVnXLiBdXiZ3wpjxnFILu02480flTvFxtcpXRzvktBc7scZ5rr9Kt7a4hDW97ChPWOQ4INZxaykOfMB/CjybNhww/Koi+UqS5johpl31QwyD1WQU77BeDrD+TCudWGFP8AVyOP93NTRkKeZ7j8zV+0I9mzd+xXfdAPq1Na1kzh5ol9t2azFMJPLTsPcmp45LaLlEIPqVo9ohcjJbhVjUIjFj1J7UujDGvaaf8Ap4j/APQhVeS5j6kt+VbvgjQ77xBqcE+lRpLHbToZNzhSOewPWiU421ZSi1oj6/T7i/SlpsYIjUHrgU6vCPSCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA4f41+F7/xp8MtZ0DRzAt9d+T5ZncqnyTRuckA9lPasT4h+A9X8QeI/El9YNaiHUPCraND5khB88zO+SMcLhhz+lep0UAfP1z8ErmOfVZtOsNGt5WfR5LB0GwwPBj7UwIX5S+ByOW71paH8KtX034ltrdyLW7g/tabUor8XnlSokmQY3j8gs5AO3/WhcY4HSvb6KAOB1mCfTvjJomry2802n32lzaUJo4y4t5vNWVd+Puq4BGfVQDXmlr8F/EhTxHaRT6Zpdpf2dxCjiUXUrSySB+JfJSVIzghlZ5Dg98DH0TRQB8+2Xwg1yOyeT7BpKSJqNnfS6bLfeZa3/kJIrKwS3RYwd6EfK+SvzetWPE3wp1zVw8lvo/hi2F5pj6eLQTP5eku1y8vnwERfMxDDOAnzDg44r3qigDwzWvg/fXt14gvhHp1xq0+qafdWF/McTJFCIxJ823KltjcA4PFNi+FuvxeMILz7LossUXiGfV21QzuLuaKRWCxMuzIC5A4fHAwBXutFAHhXw/8ABmrfDSPXdW1Sys20mLTnhhsLUC9up5S+7CyLBG5Q8KEbecnJIxXpnws0a78PfDnw7pOpH/TbWyjjmGc7Wxkrn2zj8K6migAooooAKKKKACiiigAooooAKKKKACiiigAooooAxvGGoW+meGr+6vYmmt0iO9F6sPSvlLTrA+MPEt7beGwljCqebGlx82B6E19LfFk48A6t/wBcq8C+BkO7xHqspOAtui59M1Sqzpp8rsTKEZbosJ4L8WW3ySjT5UHcOQa5/wATG/8AD91Fb6jaRmWRdw8t84Fe6SDEh/fh8dsmvHPjKf8Aipbf2tx/OnHF1b7mbow7HnOraok+pxubdwduNuBTBeL/AM+7/kKztTP/ABNFP+zTQc1usXVQvYQZqrfDtA36U8Xx7QsPyrJFOBNH1yqL6vA1hfsOkbfpTv7RkH/LN/zFZKk5p+aPrlUPq8DVGpyf882/OkOpseqH86zRSUfXKvcPq8DTOojuox9a0fCusRWvifTJZWkjiW4TcI2PPPp3rmjUtgrHUbURna5lUKx7HIwaTxdV6XD2EF0P0AicSRI6/dYAinZryuPwn47nt4mPjSONSgIVLYYAxVWfwL4+Ykx+OAfrDiuY6D16ivDL3wb8VbclrLxVBP6AqB/OsS6Hxt0tsmWO5Qd0VWzQB9HUV81R/Ez4laQ//E00hJlHUPAyfr0rVtf2hltWCa7oFxAe7xMCKAufQFFeX6L8bvB+p7VN5JbSN/DKhGPxrsrfxZolxGHh1O1ZTzneBQBvUVx/iLx3pmjW6TljcxE4LQncAazfDvxEXW2BisJI42bClqAPQqKYrZA+lPoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOe8fWMuo+EtRtbeHz5ZIyFjzjJryD4Q+FdS0mfVW1GxlieXaqqeMgehr3y4TfCy+orO022eJpQxJBpNXVhPc5KTSnU5S3nDe/Irwv40LLH4sVZInAEAxx15r6tMQznqfesDXtHt7+5BubaGbC4G9AcUlCzE3ofDN+C+o5wR8vcU5YmboGJ9lNfY58J6WJMnS7P6+SKnj0G0i/1VhaJ9IRVk858bpZzv92GdvpGatRaNfSf6uxvG+kJr7IWwZB+7jhX6RCpkjulwBLgeygUWFznx3F4Y1l/9XpN+3/bI1ZTwd4hf7miX5/7Z19eFb3tcSYpDHeH/AJeJfzosHOfJsfgTxMw40K+/75qQeAvEx66HeflX1YYLo5zNKf8AgVR/Y5W6vIfq1Fhcx8sD4feJ/wDoC3X6Vd0P4feJF1iyabRp/KWZCxJAwM19M/YJP9o/jUkdlJuXhuvrQHMdTCPLhjQDhVA/SnFzVIWNwANl23TuKabS+xxcqfwpGl32Lxc9hSb2rNaz1DtOKiax1In/AF/H1oFzPsasm2RcSxqw9GGaxNa8P+H9UiKapptlKuP4lAP6VJ/Zt+3DT/8Aj1NPh9pG3TzfgOaAu+x5rrHwc8BXExmt2ntJM52wyZX8qy5/hNpeMWupXCKPRea9ni8P2i43AsR+FXI9NtkGFhWgVpM4Twr4U0vQtPjWRJL3HQTcjPriuqsJ7UELBZxxDOPlQCtdbaJQAEUAdOKesMa9EUfhQNJhEhHJNS0UUFhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAEZpuMHpTqKAG49qayBuq5qSigCHyEz92jyE/uVNRQKxB5CdlpPIT+5ViigLIreQvZKPJX/nnVmigOVFbyl/550CJc/cqziigXKiARD+4MUCJc/dqeigfKhvPpRz6U6igY3n0pOfSn0UAN59KKdRQAlFLRQAUUGigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The iNeb nebulizer monitors the patient's breathing pattern and injects the aerosolized medication at the start of each inhalation. It is used for the administration of iloprost.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_56_23439=[""].join("\n");
var outline_f22_56_23439=null;
